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ABSTRACT	1	 	2	 Replication	 fork	stalling	and	accumulation	of	single-stranded	DNA	trigger	 the	S	3	 phase	 checkpoint,	 a	 signalling	 cascade	 that,	 in	 budding	 yeast,	 leads	 to	 the	4	 activation	 of	 the	 Rad53	 kinase.	 Rad53	 is	 essential	 in	maintaining	 cell	 viability,	5	 but	its	targets	of	regulation	are	still	partially	unknown.	Here	we	show	that	Rad53	6	 drives	the	hyper-SUMOylation	of	Pol2,	the	catalytic	subunit	of	DNA	polymerase	ε,	7	 principally	 following	 replication	 forks	 stalling	 induced	by	nucleotide	depletion.	8	 Pol2	is	the	main	target	of	SUMOylation	within	the	replisome	and	its	modification	9	 requires	 the	SUMO-ligase	Mms21,	a	 subunit	of	 the	Smc5/6	complex.	Moreover,	10	 the	 Smc5/6	 complex	 co-purifies	 with	 Pol	 ε,	 independently	 of	 other	 replisome	11	 components.	 Finally,	 we	 map	 Pol2	 SUMOylation	 to	 a	 single	 site	 within	 the	 N-12	 terminal	 catalytic	 domain	 and	 identify	 a	 SUMO-interacting	 motif	 at	 the	 C-13	 terminus	of	Pol2.	These	data	suggest	that	the	S	phase	checkpoint	regulate	Pol	ε	14	 during	replication	stress	through	Pol2	SUMOylation	and	SUMO-binding	ability		15	 	16	 	 	17	
	 3	
AUTHOR	SUMMARY	1	 	2	 Chromosome	duplication	 is	essential	 for	cell	proliferation.	Mistakes	during	 this	3	 process	introduce	mutations,	duplications,	deletions	and	rearrangements	of	the	4	 genetic	 information.	 Cells	 have	 evolved	 a	monitoring	 pathway	 that	 supervises	5	 DNA	 replication,	 called	 S	 phase	 checkpoint;	 this	 regulates	many	 aspects	 of	 the	6	 cell	 biology	 in	 response	 of	 defects	 during	 DNA	 replication,	 so	 to	 promote	 the	7	 complete	 and	 faithful	 completion	 of	 DNA	 replication	 once	 the	 obstacles	 are	8	 eliminated.	While	many	details	 of	 the	 S	phase	 checkpoint	 are	known,	how	 this	9	 pathway	 regulates	 the	 machine	 copying	 the	 DNA	 is	 still	 largely	 poorly	10	 understood.	 Here	 we	 present	 a	 novel	 mechanism	 of	 action	 of	 the	 S	 phase	11	 checkpoint	preferentially	observed	 in	response	to	replication	 forks	stalling.	We	12	 show	that	the	catalytic	subunit	of	DNA	Pol	ε	(Pol2),	 is	the	preferential	target	of	13	 modification	 with	 SUMO	 among	 the	 replication	 machinery	 components.	 This	14	 mono-SUMOylation	depends	on	the	S	phase	checkpoint	factors	Rad53,	Mrc1	and	15	 Ctf18.	Moreover,	Pol	ε	is	bound	and	SUMOylated	by	the	Smc5/6	complex.	Finally,	16	 we	 identified	 the	 site	 of	 the	 Pol2	 modification	 and	 a	 SUMO	 binding-motif,	17	 suggesting	a	possible	mechanism	of	action	for	this	modification.	18	 	 	19	
	 4	
INTRODUCTION	1	 	2	 The	 maintenance	 of	 genome	 stability	 requires	 the	 faithful	 and	 complete	3	 duplication	 of	 the	 chromosomes	 in	 each	 cell	 cycle.	 Therefore,	 pathways	4	 controlling	the	formation,	activity	and	repair	of	replication	forks	play	a	key	role	5	 in	safeguarding	cell	viability	and	act	as	a	bulwark	against	cell	transformation	(1,	6	 2).	These	pathways	must	be	coordinated,	integrating	different	stimuli	within	the	7	 cell,	and	the	cross-talk	between	different	post-translational	modifications	plays	a	8	 critical	 role	 in	 their	 regulation.	 For	 example,	 the	 initiation	 of	 chromosome	9	 replication	 is	 positively	 regulated	 by	 the	 phosphorylation	 of	 Mcm4	 by	 DDK	10	 (Dbf4-dependent	kinase)	(3-5),	and	negatively	controlled	by	SUMOylation	of	the	11	 origin-bound	 double	 hexamer	 of	 Mcm2-7.	 In	 fact,	 SUMOylation	 promotes	 the	12	 recruitment	of	Rif1	and	 the	Glc7	phosphatase,	 thus	 reversing	DDK	activity	and	13	 counteracting	 origin	 firing	 (6-8).	 	 The	 analysis	 of	 the	 cross-talk	 of	 different	14	 signalling	 pathways	 is	 therefore	 often	 necessary	 to	 understand	 how	 complex	15	 processes	are	fine-tuned.	16	 	17	 Origin	 firing	 leads	 to	 the	assembly	of	 the	replisome,	which	 faithfully	duplicates	18	 the	entirety	of	the	genome	(9).	Eukaryotic	replisomes	consist	of	the	CMG	helicase	19	 (Cdc45/Mcm2-7/GINS),	DNA	polymerase	epsilon	(Pol	ε)	–	which	synthesises	the	20	 leading	 strand	 at	 replication	 forks	 -,	 DNA	 polymerase	 alpha	 (Pol	 α),	 -	 which	21	 makes	RNA-DNA	primers	for	Okazaki-fragments	synthesis	before	their	handover	22	 to	DNA	polymerase	delta	(Pol	∂)	during	lagging	strand	synthesis	-,	and	a	series	of	23	 other	 factors	 that	 structurally	 and	 functionally	 coordinate	 the	 activity	 of	 DNA	24	 unwinding	and	DNA	synthesis,	such	as	the	Mrc1/Tof1/Csm3	sub-complex	or	the	25	
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trimeric	 “interaction	 hub”	 Ctf4	 (10-12).	 The	 replisome	 then	 duplicates	 the	1	 chromosome	template	at	rates	between	1	and	2	kb	min−1	(13,	14).	Nevertheless,	2	 many	 obstacles	 can	 impede	 the	 progression	 of	 replication	 forks,	 ranging	 from	3	 DNA-protein	 or	 DNA/RNA	 barriers,	 insults	 of	 the	 DNA	 template	 caused	 by	4	 endogenous	 and	 exogenous	 sources,	 or	 insufficient	 levels	 of	 dNTPs	 for	5	 processive	DNA	synthesis.	All	these	obstacles	ultimately	halt	the	progression	of	6	 the	fork	and	are	often	collectively	referred	to	as	‘replication	stress’	(2,	15).	These	7	 challenges	 to	 replication	 differ	 in	 nature	 and	 require	 different	 strategies	 to	8	 overcome	 them.	 For	 example,	 whereas	 damage	 caused	 by	 UV	 light	 causes	 the	9	 build-up	of	 single-stranded	DNA	(ssDNA)	gaps	behind	 the	 fork,	 treatment	with	10	 hydroxyurea	 (HU)	 leads	 to	 limited	 ssDNA	 accumulation	 close	 to	 the	 replisome	11	 (16,	 17).	 In	 response	 to	 this	 accumulation,	 cells	 activate	 the	 S	 phase	 and	DNA	12	 damage	 checkpoints,	 two	overlapping	but	distinct	 pathways	 that	 recognise	 the	13	 accumulation	of	single-stranded	DNA	at	replication	forks	or	closely	behind	them,	14	 respectively	(18).	In	budding	yeast,	both	pathways	require	the	activation	of	the	15	 checkpoint	kinase	Mec1,	which	critically	phosphorylates	the	mediators	Mrc1	and	16	 Rad9	 (most	 prominently	 for	 the	 S	 phase	 and	 DNA	 damage	 checkpoint,	17	 respectively).	 	This	 leads	 to	 the	 recruitment,	phosphorylation	and	activation	of	18	 the	effector	kinase	Rad53,	which	regulates	several	different	pathways	in	the	cell,	19	 including	 cell	 cycle	 control,	 inhibition	 of	 late	 origin	 firing,	 gene	 expression,	20	 regulation	 of	 nucleases	 and	 helicases,	 and	 control	 of	 chromatin	 remodelling	21	 enzymes	 (19,	 20).	 Strikingly,	 checkpoint	 kinases	 also	 phosphorylate	 several	22	 replisome	 components,	 such	 as	 Cdc45,	 Ctf4,	 Tof1,	 Dpb4,	 Pol	 31,	 Pol1,	 several	23	 MCMs	 subunits	 and	 GINS	 (21-26).	 This	 suggests	 that	 the	 replisome	 is	 an	24	 important	 target	 of	 checkpoint	 regulation,	 possibly	 ensuring	 the	 coordination	25	
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between	 DNA	 synthesis	 and	 replisome	 progression	 (21,	 27-29),	 although	 the	1	 details	of	such	regulation	are	still	poorly	understood.		2	 	3	 In	 addition	 to	 phosphorylation	 by	 the	 checkpoint	 kinases,	 ubiquitylation	 and	4	 SUMOylation	 also	 play	 a	 key	 role	 in	 the	 response	 to	 replication	 forks	 stalling.		5	 One	 of	 the	 best-characterised	 targets	 of	 ubiquitylation	 in	 response	 to	 DNA	6	 damage	 is	 the	 PCNA	 clamp,	 which	 is	 mono-ubiquitylated	 by	 Rad6-Rad18	 and	7	 poly-ubiquitylated	by	Rad5-Ubc13-Mms2.	These	modifications	regulate	the	post-8	 replicative	repair	of	gaps	 left	behind	replication	 forks	and	promote	either	DNA	9	 damage	 tolerance	 (mono-ubiquitylation)	 or	 error-free	 repair	 and	 sister	10	 chromatid	 recombination	 (poly-ubiquitylation)	 (30).	 Similarly,	 SUMOylation	11	 promotes	cell	viability	in	response	to	replication	defects.	Budding	yeast	contains	12	 a	simple	SUMOylation	pathway,	with	a	single	E2	SUMO-conjugating	enzyme	and	13	 three	 PIAS-family	 E3	 SUMO	 ligases,	 namely	 Siz1,	 Siz2	 and	 Mms21	 (31,	 32).	14	 Mutation	of	 the	E2	conjugating	enzyme	Ubc9	results	 in	sensitivity	 to	 treatment	15	 with	MMS	and	HU,	as	does	mutation	of	the	E3	ligase	MMS21,	or	the	simultaneous	16	 deletion	of	SIZ1	and	SIZ2	(32-34).		17	 	18	 Many	 targets	 of	 SUMOylation	 have	 been	 characterised	 in	 response	 to	 MMS	19	 treatment,	 such	 as	 the	 helicase	 Sgs1,	 the	 Cohesin	 subunit	 Scc1	 or	 the	20	 recombination	 factor	 Rad52	 (35-43).	 	 Abolishing	 the	 SUMOylation	 of	 these	21	 targets	 leads	 to	 changes	 in	 the	 dynamics	 and	 location	 of	 DNA	 repair,	22	 chromosome	instability	and	loss	of	viability.	Moreover,	SUMO-ligases	localise	to	23	 sites	of	ssDNA	accumulation	and	modify	proteins	recruited	nearby,	in	a	manner	24	 that	 is	 mainly	 driven	 by	 proximity	 to	 the	 damage	 or	 to	 the	 recombination	25	
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intermediates	 (44).	The	role	of	 such	 large-scale	modification	appears	 to	 favour	1	 protein-protein	interactions	amongst	repair	proteins,	thus	hastening	the	kinetics	2	 of	 repair.	Therefore,	waves	of	SUMOylation	act	 as	a	molecular	glue	 that	 favour	3	 DNA	damage	repair.	 Interestingly,	 several	 replisome	proteins	and	other	 factors	4	 at	forks	are	similarly	modified	in	response	to	MMS	raising	the	possibility	that	a	5	 similar	function	might	occur	at	forks	(33).			6	 	7	 Together,	 the	 checkpoint	 response	 and	 protein	 SUMOylation	 both	 ensure	 the	8	 maintenance	 of	 cell	 viability	 following	 DNA	 damage.	 Interestingly,	 several	9	 observations	 suggest	 some	 cross-talk	 between	 these	 pathways.	 In	 fact,	10	 SUMOylation	regulates	the	S	phase	and	DNA	damage	checkpoints.	For	example,	11	 in	budding	yeast,	Mec1,	Tel1	Rad9	and	Mrc1	are	all	SUMOylated	in	response	to	12	 MMS	treatment;	in	human	cells,	ATRIP	is	SUMOylated,	thus	boosting	its	binding	13	 to	 ATR,	 RPA70,	 TopBP1,	 and	 the	 MRE11-RAD50-NBS1	 complex	 (44,	 45).	14	 Similarly,	ATR	SUMOylation	increases	its	catalytic	activity	(46).	15	 	16	 Conversely,	 the	 S	 phase	 checkpoint	 also	modulates	 the	 SUMOylation	 response.		17	 In	budding	yeast,	Mec1	and	Tel1	checkpoint	kinases	phosphorylate	Mms21,	and	18	 stimulate	 the	 SUMOylation	 of	 Snf1	 (47,	 48).	 	 Similarly,	 human	 FANCI	 and	19	 FANCD2	 are	 SUMOylated	 in	 response	 to	 replication	 fork	 stalling	 in	 an	 ATR-20	 dependent	manner	(49).		In	contrast,	SUMOylation	of	many	proteins	is	increased	21	 in	the	absence	of	budding	yeast	Mec1	(33).	Similar	results	have	been	observed	in	22	 human	 cells	 following	 the	 inhibition	 of	 ATR	 (50).	 It	 remains	 to	 be	 determined	23	 whether	this	increase	reflects	a	direct	inhibitory	role	of	the	checkpoint	response	24	 on	 SUMOylation,	 or	 else	 it	 is	 a	 consequence	 of	 increased	 DNA	 damage	 in	 the	25	
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absence	of	the	checkpoint	kinases.	Nevertheless,	 the	 level	and	the	regulation	of	1	 the	 cross-talk	 between	 the	 checkpoint	 response	 and	 protein	 SUMOylation	 are	2	 still	understood	poorly.		3	 	4	 Here	we	report	a	site-specific	SUMOylation	of	the	Pol2	catalytic	subunit	of	Pol	ε,	5	 which	depends	on	the	Smc5/6	complex	and	is	stimulated	robustly	in	response	to	6	 the	activation	of	the	S	phase	checkpoint	by	fork	stalling	with	hydroxyurea	(HU).	7	 Moreover,	 we	 map	 a	 SUMO	 interacting	 Motif	 at	 the	 C-terminal	 of	 Pol2. Our	8	 findings	 suggest	 a	 model	 for	 the	 possible	 regulation	 of	 Pol2	 by	 SUMOylation	9	 following	replication	stress.		10	 	11	
RESULTS	12	 	13	
Pol2	is	mono-SUMOylated	in	response	to	nucleotide	depletion.	14	 	15	 Whilst	searching	for	novel	post-translational	modifications	of	the	replisome	(De	16	 Piccoli	 et	 al,	 2013;	 Maric	 et	 al	 2014),	 we	 discovered	 that	 the	 Pol2	 catalytic	17	 subunit	 of	 Pol	 ε	 was	 modified	 in	 response	 to	 nucleotide	 depletion	 by	18	 hydroxyurea	 (HU,	 Fig	 1A).	 	 Interestingly,	 this	 effect	was	 preferentially	 seen	 in	19	 response	to	nucleotide	depletion,	compared	to	what	observed	in	cells	incubated	20	 with	 the	 alkylating	 agent	 methylmethane	 sulphonate	 (MMS),	 or	 the	21	 topoisomerase	I	poison	Camptothecin	(CPT).	Moreover,	the	induction	of	double	22	 strand	 breaks	 outside	 of	 S	 phase	with	 Zeocin	 treatment	 did	 not	 promote	 Pol2	23	 modification	(Fig	1A).		24	 	25	
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After	isolation	of	Pol	ε	by	immunoprecipitation	of	the	Dpb2	subunit,	we	observed	1	 that	 modified	 Pol2	 was	 resistant	 to	 phosphatase	 treatment	 and	 was	 not	2	 recognised	 by	 antibodies	 to	 ubiquitin	 (S1	 Fig	 A-B).	 In	 contrast,	 modified	 Pol2	3	 was	recognised	by	antibodies	specific	for	yeast	SUMO	(Fig	1B)	and	represented	4	 one	 of	 the	 most	 abundant	 SUMO	 conjugates	 in	 the	 cell	 extracts.	 	 Moreover,	5	 SUMOylated	Pol2	could	also	be	detected	in	untreated	S	phase	cells,	 though	to	a	6	 10-fold	lower	level	than	after	HU	treatment	(Fig	1B,	S1	Fig	C-D).				7	 	8	 To	 address	 whether	 Pol2	 SUMOylation	 occurs	 at	 replication	 forks	 or	 in	 the	9	 fraction	not	associated	with	DNA,	we	 treated	cells	with	 formaldehyde	 to	cross-10	 link	proteins	to	DNA,	and	then	made	extracts	containing	high	salt	and	detergents,	11	 so	 that	any	observed	complexes	would	reflect	 the	 in	vivo	 situation,	 rather	 than	12	 interactions	occurring	ex	vivo	(21).		In	this	way,	we	observed	that	the	fraction	of	13	 SUMOylated	 Pol2	 was	 greatly	 enriched	 after	 immunoprecipitation	 of	 Cdc45,	14	 indicating	 that	 Pol2	 SUMOylation	 occurs	 in	 the	 context	 of	 the	 replisome	 at	15	 replication	forks	(Fig	1C).		16	 	17	 Finally,	 we	 compared	 the	 size	 of	 the	 observed	 Pol2-SUMO	 band	with	markers	18	 representing	Pol2-5FLAG	(7.2	kDa	larger	than	wild	type	Pol2)	or	a	linear	fusion	19	 of	Pol2	and	a	non-conjugatable	 form	of	 the	yeast	 SUMO	Smt3	 (12.5	kDa	 larger	20	 than	wild	type	Pol2).		After	immunoprecipitation	of	Pol	ε	from	cells	treated	with	21	 HU,	the	SUMOylated	form	of	wild	type	Pol2	was	seen	to	migrate	equivalently	to	22	 the	Pol2-Smt3	fusion	protein	(Fig	1D),	indicating	that	Pol2	is	mono-SUMOylated	23	 in	response	to	nucleotide	depletion.	Taken	together,	these	findings	indicate	that	24	 Pol2	is	mono-SUMOylated	at	replication	forks;	this	modification	occurs	at	a	low	25	
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level	during	unchallenged	DNA	replication,	and	is	greatly	stimulated	in	response	1	 to	nucleotide	depletion.	2	 	3	
Pol2	is	the	main	target	of	SUMOylation	within	the	core	replication	machine.	4	 	5	 Previous	work	showed	that	DNA	damage	induces	a	wave	of	protein	SUMOylation	6	 that	affects	many	proteins	and	works	as	a	 “molecular	glue”	 to	promote	protein	7	 interaction	and	thus	increase	the	kinetics	of	repair	and	favour	cell	growth	(44).	8	 Similarly,	 many	 replication	 proteins,	 including	 Pol2,	 show	 a	 basal	 level	 of	9	 SUMOylation	in	S	phase	(Fig	1B)	and	are	SUMOylated	in	response	to	high	levels	10	 of	 MMS	 (Cremona	 et	 al.,	 2012).	 In	 contrast,	 in	 our	 experiments,	 anti-SUMO	11	 immunoblots	of	whole	cell	extracts	 indicated	that	a	single	band	was	prominent	12	 after	 HU	 treatment,	 corresponding	 to	 Pol2-SUMO	 (Fig	 1B,	 left	 panel).	 This	13	 suggested	 that	 increased	 SUMOylation	 of	 Pol2	 in	 response	 to	 nucleotide	14	 depletion	might	 be	 specific	 and	 not	 be	 part	 of	 a	 SUMOylation	 wave	 of	 all	 the	15	 neighbouring	proteins.	16	 	17	 To	explore	this	further,	we	tested	directly	whether	other	DNA	polymerases	were	18	 also	SUMOylated	following	HU	treatment.	Cells	carrying	TAP-tagged	alleles	of	the	19	 second	 largest	 subunits	 of	 the	 three	 replicative	 DNA	 polymerases	 (namely	20	
POL12-TAP,	POL31-TAP	 and	DPB2-TAP	 for	 Pol	α,	 Pol	δ	 and	 Pol	 ε,	 respectively)	21	 were	arrested	in	G1	and	then	released	into	S	phase	in	the	presence	or	absence	of	22	 HU.	 	 After	 immunoprecipitation	 and	 stringent	 washing,	 the	 polymerase	23	 complexes	 were	 released	 from	 beads	 by	 TEV	 cleavage	 and	 analysed	 by	 mass	24	 spectrometry	 (S2	 Fig,	 confirming	 the	 presence	 of	 all	 predicted	 subunits)	 and	25	
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immunoblotting	with	antibodies	 to	 the	residual	portion	of	 the	TAP-tag	(Fig	2A,	1	 left	panel)	or	yeast	SUMO	(Fig	2A,	right	panel).	 	We	observed	that	Pol2	was	the	2	 only	polymerase	subunit	to	be	SUMOylated	under	these	conditions,	and	this	was	3	 greatly	 increased	 in	 the	 presence	 of	 HU.	 Furthermore,	 we	 analysed	 replisome	4	 material	 that	 was	 isolated	 by	 immunoprecipitation	 of	 TAP-tagged	 Sld5,	 a	5	 component	of	the	GINS	complex	and	the	CMG	helicase.	 	No	further	SUMOylated	6	 proteins	 were	 detected	 in	 HU-treated	 cells,	 (Fig	 2B).	 All	 together,	 these	 data	7	 show	that	Pol2	is	a	preferential	target	of	SUMOylation	within	the	core	replication	8	 machine,	 in	 response	 to	 nucleotide	 depletion,	 and	 indicate	 that	 Pol2	9	 SUMOylation	does	not	 occur	 in	 the	 context	 of	 a	 ‘promiscuous	wave’	 of	 general	10	 SUMOylation	 at	 replication	 forks	 under	 these	 conditions,	 contrasting	 with	 the	11	 response	to	double	strand	breaks	and	MMS	treatment.		12	 	13	
Pol2	hyper-SUMOylation	in	HU	is	dependent	on	the	S	phase	checkpoint.		14	 	15	 To	 investigate	 whether	 Pol2	 SUMOylation	 following	 nucleotide	 depletion	 is	16	 dependent	 upon	 the	 S	 phase	 checkpoint,	 we	 initially	 monitored	 Pol2	17	 SUMOylation	in	cells	lacking	the	yeast	checkpoint	kinases	Mec1,	Rad53	and	Dun1	18	 (Fig	3A).		As	described	above,	Pol2	SUMOylation	was	detected	in	control	cells,	as	19	 well	as	in	dun1∆	cells	(Fig	3B).	However,	increased	levels	of	SUMOylation	of	Pol2	20	 were	not	detected	in	cells	lacking	MEC1	or	RAD53	(Fig	3B).	Since	Mec1	and	Dun1	21	 are	 respectively	 upstream	 and	 downstream	 of	 Rad53	 activation	 (51,	 52),	 we	22	 conclude	 that	 Pol2	 SUMOylation	 is	 Rad53-dependent.	 Consistent	 with	 this	23	 hypothesis,	 Pol2	 SUMOylation	 in	 HU	 is	 dependent	 upon	Mrc1	 and	 Ctf18,	 both	24	 mediators	of	Rad53	activation	at	forks	(53-55),	but	was	independent	of	the	DNA	25	
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damage	checkpoint	mediator	Rad9	(56,	57)	or	the	dsDNA	break	response	factor	1	 Mre11	 (58,	 59)	 (Fig	 3C,	 S3	 Fig	 A).	 	Moreover,	 the	 dependency	 on	 the	 S	 phase	2	 checkpoint	 for	the	 increase	 in	SUMOylation	was	observed	mainly	 in	HU	(S3	Fig	3	 B).	 Interestingly,	 we	 observed	 that	 the	 mrc1-AQ	 allele	 did	 not	 affect	 the	4	 SUMOylation	of	Pol2,	suggesting	that	the	delay	in	Rad53	checkpoint	activation	in	5	 this	background	was	insufficient	to	abolish	the	S	phase	checkpoint	response,	as	6	 previously	observed	(54).		7	 	8	 Finally,	 we	 compared	 Pol2	 SUMOylation	 with	 the	 kinetics	 of	 checkpoint	9	 activation,	as	reflected	by	Rad53	hyper-phosphorylation.	We	observed	that	Pol2	10	 SUMOylation	 lags	 behind	 the	 hyper-phosphorylation	 of	 Rad53,	 consistent	with	11	 Pol2	 SUMOylation	 being	 downstream	 of	 checkpoint	 activation	 (Fig	 3D).	12	 Moreover,	the	fraction	of	Pol2	that	is	SUMOylated	was	increased	in	dbf4-4A	sld3-13	
37A	cells	which	cannot	restrain	late	origin	firing	in	HU	(60),	consistent	with	the	14	 observation	 that	Pol2	SUMOylation	mostly	occurs	at	 replication	 forks	 (Fig	3D).		15	 All	 together,	 we	 conclude	 that	 Pol2	 is	 SUMOylated	 as	 part	 of	 the	 replisome,	16	 dependent	 upon	 activation	 of	 the	 Rad53	 kinase	 by	 the	 S	 phase	 checkpoint	17	 pathway.		18	 	19	
Pol2	SUMOylation	requires	the	Mms21	SUMO-ligase	subunit	of	the	Smc5/6	20	
complex.	21	 	22	 In	budding	yeast	cells,	the	SUMOylation	pathway	depends	on	a	single	E1	SUMO-23	 activating	enzyme	Aos1/Uba2,	a	single	E2	SUMO-conjugating	enzyme	Ubc9,	and	24	 three	E3	SUMO-ligases,	namely	Siz1,	Siz2	and	Mms21	(31,	61).	Whereas	Siz1	and	25	
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Siz2	are	not	needed	 for	 cell	 viability,	Mms21	 is	essential,	 although	 this	 reflects	1	 other	roles	in	addition	to	its	SUMO-ligase	activity	(34,	62,	63).	Mms21	(or	Nse2)	2	 is	part	of	the	conserved	Smc5/6	complex,	an	8-subunits	complex	that	safeguards	3	 genome	stability	in	response	to	double	strand	breaks	or	obstacles	to	replication	4	 fork	 progression,	 and	 regulates	 the	 topological	 status	 of	 chromosomes	 during	5	 and	following	DNA	replication	(32,	38,	64-70).		6	 	7	 To	investigate	which	SUMO	E3	ligases	might	be	required	for	Pol2	SUMOylation,	8	 we	 isolated	 Pol	 ε	 from	 cells	 lacking	 Siz1	 or	 Siz2,	 or	 from	 cells	 after	 rapid	9	 depletion	of	Mms21	via	an	auxin	degron	cassette	(71).	As	shown	in	Fig	4A,	Pol2	10	 SUMOylation	 was	 unaffected	 in	 siz1∆	 or	 siz2∆	 cells,	 but	 was	 abolished	 in	 the	11	 absence	of	Mms21	 (Fig	4A).	This	 indicated	 that	 the	 Smc5/6	 complex,	 of	which	12	 Mms21	 is	 a	 subunit,	 drives	 Pol2	 SUMOylation.	 	 Correspondingly,	 Pol2	13	 SUMOylation	was	 prevented	 by	 depletion	 of	 a	 degron-tagged	 version	 of	 Smc5,	14	 (Fig	4B).		Interestingly,	depletion	of	the	Scc2-4,	the	loading	complex	for	Smc5/6	15	 (65,	 68)	did	not	 abolish	Pol2	 SUMOylation	 (Fig	4B),	 despite	blocking	 cell	 cycle	16	 progression	and	causing	loss	of	cell	viability	(S4	Fig	A,	B),	suggesting	that	at	least	17	 some	 of	 the	 functions	 of	 Smc5/6	 complex	 at	 stalled	 forks	 are	 independent	 of	18	 Scc2-4.	 	 Finally,	 the	 basal	 level	 of	 SUMOylation	 observed	 in	 S	 phase	 also	19	 depended	on	Mms21,	but	not	Rad53,	suggesting	that	the	latter	is	only	needed	for	20	 the	10-fold	increase	in	SUMOylation	observed	in	HU	(S3	Fig	B,	S5	Fig	A,	B).	21	 	22	 To	explore	whether	Mms21	directly	SUMOylates	Pol2,	we	 first	mutated	 the	sp-23	 RING	(Siz1/PIAS	RING)	domain	of	Mms21,	which	binds	the	Ubc9	E2	enzyme	for	24	 SUMOylation.	 	Pol2	SUMOylation	was	abolished	in	the	mms21-C200A	H202A	sp-25	
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RING	 mutant	 (mms21-CH),	 indicating	 that	 Pol2	 SUMOylation	 requires	 the	 E3	1	 ligase	activity	of	Mms21	(S5	Fig	C).	We	then	tested	whether	Mms21	was	able	to	2	 directly	SUMOylate	Pol2	in	vitro.		To	this	end,	we	purified	Pol	ε,	Smc5/6-Mms21	3	 and	Smc5/6-mms21-CH	from	budding	yeast	cells,	and	then	incubated	them	with	4	 recombinant	budding	yeast	E1,	E2	and	SUMO	proteins	that	were	purified	from	E.	5	
coli.	In	vitro	SUMOylation	of	Pol2	depended	not	only	on	the	E1	and	E2	enzymes,	6	 but	also	upon	the	RING	domain	of	Mms21	(Fig	4C,	compare	titrations	of	Mms21	7	 and	 Mms21-CH).	 Similarly,	 expression	 of	 wild	 type	 Mms21	 was	 sufficient	 to	8	 drive	 in	 vivo	 Pol2	 SUMOylation	 in	mms21-CH	 cells	 arrested	 in	 HU	 (S5	 Fig	 D).	9	 These	 findings	 indicate	 that	 Pol2	 is	 a	 direct	 target	 of	 the	 Mms21-Smc5/6	 E3	10	 SUMO	ligase,	both	in	vitro	and	in	vivo.	11	 	12	 Previous	 studies	 indicated	 that	 SUMOylation	 of	 target	 proteins	 by	 Mms21	13	 depends	not	only	on	the	integrity	of	the	Smc5/6	complex,	but	also	on	the	binding	14	 to	 the	BRCT-containing	 protein	Rtt107,	 at	 least	 in	 response	 to	MMS	 treatment	15	 (56,	 72).	 Moreover,	 deletion	 of	 ESC2,	 a	 regulator	 of	 recombination	 containing	16	 SUMO-like	domains,	 affects	 the	SUMOylation	of	 several	Mms21	 targets,	 in	both	17	 budding	 and	 fission	 yeasts	 (73-75).	 To	 test	 whether	 RTT107	 and	 ESC2	 were	18	 required	 for	 the	SUMOylation	of	Pol2	 in	HU,	wild	 type,	rtt107∆	 and	esc2∆	 cells	19	 were	incubated	in	HU,	before	immunoprecipitation	of	and	immunoblotting	of	Pol	20	
ε.	We	 observed	 that	 Pol2	 SUMOylation	was	 decreased	 in	 the	 absence	 of	 either	21	 Rtt107	 or	 Esc2	 (Fig	 4D),	 suggesting	 that	 these	 factors	 promote	 robust	22	 SUMOylation.		23	 	24	
Pol2	co-purify	with	Smc5/6	25	
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	1	 Since	the	SUMOylation	of	Pol2	was	exclusively	dependent	on	Mms21,	we	tested	2	 whether	 Pol	 ε	 associates	 with	 the	 Smc5/6-Mms21	 E3	 ligase	 complex,	 using	3	 strains	with	tagged	versions	of	Dpb2,	Smc5	or	Mms21.		Cells	were	arrested	in	G1	4	 phase	and	then	released	synchronously	into	S	phase	in	the	presence	or	absence	5	 of	0.2	M	HU.	As	shown	in	Fig	4E-F	and	S6	Fig	A-B,	Smc5	and	Mms21	co-purified	6	 with	Pol	ε	throughout	the	cell	cycle,	regardless	of	whether	cells	had	been	treated	7	 with	HU	 to	 activate	 the	 S	phase	 checkpoint	pathway.	These	observations	were	8	 reminiscent	of	previous	data	showing	that	the	Ctf18	complex	interacts	with	Pol	ε	9	 throughout	 the	 cell	 cycle	 (76-78).	 	 Moreover,	 the	 association	 of	 Pol	 ε	 with	10	 Smc5/6-Mms21	 and	 Ctf18-RFC	 showed	 a	 similar	 salt	 sensitivity	 (S6	 Fig	 C).	11	 However,	 the	 association	 of	 Smc5/6-Mms21	 with	 Pol	 ε	 was	 independent	 of	12	 Ctf18-RFC	(Fig	4G).		13	 	14	 To	 confirm	 that	 Smc5/6-Mms21	 interacts	 with	 Pol	 ε	 independently	 of	 the	 S	15	 phase	 checkpoint	 pathway,	 we	 showed	 that	 their	 association	 still	 persisted	 in	16	 cells	lacking	the	checkpoint	kinases	Rad53	or	Mec1	(Fig	4G,	S6	Fig	D).	Moreover,	17	 the	 interaction	 between	 Smc5/6-Mms21	 and	 Pol	 ε	 did	 not	 require	 the	 SUMO-18	 ligase	 activity	 of	 Mms21	 (S6	 Fig	 D).	 All	 together,	 these	 data	 indicate	 that	 the	19	 association	 of	 Pol	 ε	 with	 the	 Smc5/6-Mms21	 complex	 is	 independent	 of	 other	20	 replisome	components	and	does	not	depend	on	the	S	phase	checkpoint.		21	 	22	
Pol2	is	SUMOylated	at	K571	23	
	24	
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To	map	 the	SUMOylation	 site(s)	within	Pol2,	we	 first	 investigated	whether	 the	1	 modification	occurs	within	the	amino-terminal	half	of	 the	protein	 that	contains	2	 the	 active	 polymerase	 domain,	 or	 maps	 to	 the	 non-catalytic	 carboxy-terminal	3	 half,	or	both.	To	this	end,	we	modified	the	POL2	locus	in	yeast	cells	to	introduce	4	 3xTEV	sites	within	the	flexible	unstructured	region	in	the	middle	of	the	protein,	5	 and	 also	 added	 a	 C-terminus	 9MYC	 tag.	 We	 used	 the	 latter	 to	 purify	 TEV-6	 cleavable	Pol	ε	 from	HU-arrested	 cells,	 and	 then	 analysed	 the	products	 of	TEV	7	 cleavage	with	antibodies	specific	to	the	N-terminus	of	Pol2	or	to	the	C-terminal	8	 9MYC	tag.	Whereas	the	Pol2	C-terminal	half	was	unmodified,	the	N-terminal	half	9	 of	 the	 protein	 showed	 an	 extra	 band	 that	 was	 dependent	 upon	 the	 E3	 ligase	10	 activity	 of	 Mms21	 and	 recognised	 by	 anti-SUMO	 antibodies	 (Fig	 5A).	 This	11	 indicates	that	Pol2	is	SUMOylated	within	the	N-terminal	half	of	the	protein	that	12	 contain	the	conserved	catalytic	exonucleolytic	and	polymerase	domains	(79).	To	13	 map	the	specific	site	of	modification,	we	used	mass	spectrometry	analysis	of	Pol	14	
ε	 purified	 from	 HU-treated	 cells	 (Fig	 5B).	 This	 identified	 a	 single	 SUMOylated	15	 residue	at	Lysine	571	(Fig	5C),	which	falls	within	a	predicted	consensus	site	for	16	 SUMOylation	(Ψ-K-X-E,	where	ψ	is	a	hydrophobic	amino	acid,	and	X	any	amino	17	 acid	 residue	 (80)).	To	 test	 if	K571	 is	 indeed	 the	only	 site	of	Pol2	 SUMOylation	18	 under	these	conditions,	we	modified	the	POL2	genomic	locus	to	produce	the	pol2	19	
K571R	allele.		This	was	sufficient	to	abolish	Pol2	SUMOylation	in	HU-treated	cells,	20	 as	well	 as	 the	basal	 SUMOylation	observed	 in	 S	phase	 (Fig	5D),	 indicating	 that	21	 K571	 is	 the	 only	 site	 of	 modification.	 Analysis	 of	 the	 structure	 of	 the	 Pol2	22	 catalytic	domain	showed	that	K571	is	located	on	the	outer	surface	of	the	protein,	23	 in	a	Pol	ε-specific	 insertion	within	the	palm	domain	of	the	Polymerase	B	family	24	 (81)	(Fig	5E).		25	
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	1	
Pol2	C-terminal	has	a	SUMO-binding	motif	2	 	3	 Protein	 SUMOylation	 often	 regulates	 protein-protein	 interactions	 (31,	 82,	 83),	4	 such	 as	 the	 binding	 of	 the	 anti-recombinogenic	 helicase	 Srs2	 to	 SUMOylated	5	 PCNA	(84,	85).	 In	such	cases,	SUMO	usually	 interacts	 in	a	non-covalent	manner	6	 with	 a	 SUMO-Interacting-Motif	 (SIM)	 in	 the	 binding	 partner	 (86).	 We	 were	7	 unable	 to	 identify	 novel	 partners	 of	 SUMOylated	 Pol2	 by	 mass	 spectrometry	8	 analysis	of	HU-arrested	 cells;	we	 therefore	 tested,	 via	 yeast	 two-hybrid	 assays,	9	 whether	 Pol	 ε	 or	 any	 of	 its	 known	 interactors	might	 bind	 to	 SUMO	 (Pol2-NT,	10	 Pol2-CT,	 Dpb2,	 Dpb3,	 Dpb4,	 Mrc1).	 We	 observed	 that,	 uniquely	 amongst	 the	11	 proteins	tested,	the	Pol2	C-terminal	half	interacted	with	SUMO,	(Fig	6A,	S7	Fig	A).	12	 Subsequent	truncations	 identified	the	 last	119	amino	acids	of	Pol2	as	sufficient	13	 for	SUMO	binding	(Fig	6B,	S7	Fig	B).	This	region	contains	two	conserved	cysteine	14	 motifs	 (CysA	 and	 CysB),	 believed	 to	 co-ordinate	 either	 zinc	 ions	 or	 iron-sulfur	15	 clusters	(87,	88),	neither	of	which	were	important	for	interaction	with	SUMO	(S7	16	 Fig	 C).	 In	 contrast,	 the	 final	 30	 amino	 acids	 of	 Pol2	 were	 required	 for	 SUMO	17	 binding	(Fig	6B)	and	contains	the	sequence	2210-FDILL	-2214	which	conforms	18	 to	the	SIM	consensus	(Ψ-X-Ψ-Ψ-Ψ	-	with	Ψ=	hydrophobic,	(89)).		Mutation	of	the	19	 latter	 to	 ADAAA	 greatly	 diminished	 the	 binding	 of	 Pol2-CT	 to	 SUMO,	 without	20	 affecting	the	interaction	with	Dpb2,	indicating	that	Pol2-CT	contains	a	functional	21	 SIM	 (Fig	 6C),	 distinct	 from	 sequences	 important	 for	 assembly	 of	 the	 Pol	 ε	22	 complex	 (90).	 Consistent	 with	 this	 view,	 we	 generated	 a	 pol2-sim	 strain	 with	23	 mutations	 in	 the	 SIM	motif	within	 the	 endogenous	POL2	 locus,	 and	 found	 that	24	 the	 resulting	 protein	 was	 incorporated	 into	 Pol ε	 and	 the	 replisome,	 without	25	
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affecting	 Pol2	 SUMOylation	 in	 HU-arrested	 cells	 (Fig	 6D).	 All	 together,	 this	1	 indicates	 that	 SUMO	 might	 regulate	 not	 only	 the	 N-terminal	 part	 of	 Pol2	 by	2	 modification	of	K571,	but	also	the	C-terminal	half	via	the	SIM	motif.	3	 	4	
DISCUSSION	5	 	6	 In	budding	yeast	and	mammalian	cells,	SUMOylation	is	essential	for	cell	viability	7	 and	 defects	 in	 this	 pathway	 leads	 to	 severe	 genome	 instability.	 Both	8	 SUMOylation	and	non-covalent	 interaction	with	SUMO	affect	a	 large	number	of	9	 proteins	 (91-95);	 nevertheless,	 SUMOylation	 relies	 on	 a	 simple	 pathway	 (in	10	 particular	 when	 compared	 with	 the	 complexity	 of	 E2	 and	 E3	 enzymes	 in	 the	11	 ubiquitilation	 pathway).	Whether	 specificity	 is	 important	 and	 how	 it	might	 be	12	 achieved	is	still	poorly	understood.	13	 	14	 Here	we	show	that	the	catalytic	subunit	of	Pol	ε	is	mono-SUMOylated	in	a	highly	15	 specific	manner.	 Following	 HU	 incubation,	 Pol2	 is	 SUMOylated	 by	Mms21	 and	16	 this	depends	on	Rad53	and	 the	S-phase	 checkpoint	mediators	Ctf18	and	Mrc1.	17	 Whilst	 at	 this	 point	 we	 cannot	 exclude	 that	 other	 factors	 at	 fork	 might	 be	18	 SUMOylated	in	an	Mms21-	and	Rad53-dependent	SUMOylation	wave	in	response	19	 to	HU,	several	observations	suggest	that	this	might	not	be	the	case.	First,	while	a	20	 SUMO	“glue”	model	would	predict	uniform	levels	of	SUMOylation	among	several	21	 replisome	 components,	 our	 direct	 analysis	 of	 the	 core	 components	 of	 the	22	 replication	 machine	 provide	 evidences	 contrary	 of	 this	 model	 (Fig	 2A,	 B).	 In	23	 addition,	 amongst	 the	 other	 known	Mms21-dependent	 targets	 of	 SUMOylation	24	 present	 at	 forks	 such	 as	 Sgs1/Top3/Rim1	 and	 Scc1	 (96,	 97),	 the	 post-25	
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translational	modification	 is	mainly	 dependent	 on	MMS	 and	 is	 downstream	 of	1	 recombination	 repair,	 a	 process	 that	 is	 actively	 inhibited	 by	 HU	 (35,	 39,	 98).	2	 Moreover,	 following	 replication	 stresses,	 RAD53	 and	 MEC1	 deletions	 highly	3	 elevate	 the	 level	 of	 SUMOylation	 of	 the	 targets	 observed,	 contrary	 to	 what	4	 observed	for	Pol2	(33,	35,	99).	Finally,	the	ability	of	Pol	ε	to	interact	with	Smc5/6	5	 complex	 independently	 of	 other	 replisome	 components	 suggests	 a	 specific	6	 targeting	of	the	SUMOylation.		7	 	8	 	While	Pol2	is	SUMOylated	to	a	basal	level	during	S	phase,	and	this	modification	9	 does	 not	 depend	 on	 Rad53	 (Fig	 1B,	 S1	 Fig	 C,	 S5	 Fig	 B),	 we	 observe	 that	 fork	10	 stalling	 with	 HU	 specifically	 induces	 about	 a	 ten-fold	 increase	 in	 the	 levels	 of	11	 SUMOylation	of	Pol2	in	an	S	phase	checkpoint	dependent	manner.	At	this	point,	12	 is	still	not	clear	how	this	increased	targeting	occurs.	In	fact,	while	the	basal	level	13	 of	 SUMOylation	 observed	 in	 S	 phase	 might	 be	 explained	 by	 the	 interaction	14	 between	 the	 Smc5/6	 and	 Pol	 ε	 and	 the	 stimulatory	 effect	 of	 DNA	 on	 Mms21	15	 activity	 (100)(Fig	4E,	F),	 the	 increased	 levels	observed	 following	HU	 treatment	16	 cannot	be	explained	simply	by	modulation	of	protein-protein	interactions,	since	17	 we	measure	neither	an	increase	in	affinity	between	Pol	ε and	Smc5/6	in	HU,	nor	18	 observe	 the	 weakening	 of	 the	 interaction	 between	 these	 two	 complexes	 in	 S	19	 phase	checkpoint	mutants	 (Fig	5G,	S6	Fig	D).	Alternatively,	phosphorylation	by	20	 Rad53	 of	 Pol	 ε,	 the	 Smc5/6	 complex	 or	 other	 neighbouring	 proteins	 might	21	 increase	 the	 efficiency	 of	 SUMOylation	 (either	 by	 stimulating	 the	 catalytic	22	 activity	 of	 Mms21	 or	 by	 making	 K571	 a	 better	 substrate	 for	 modification)	 or	23	 promote	 the	 stability	 of	 the	 modification	 (by	 sheltering	 or	 protecting	 the	24	 modification	 from	 SUMO-proteases).	 While	 several	 subunits	 of	 the	 Smc5/6	25	
	 20	
complex	 and	 Pol	 ε are	 phosphorylated	 following	 HU	 incubation	 such	 as	 Dpb2,	1	 Dpb3,	 Dpb4,	 Mms21,	 Nse4	 and	 Nse6	 (22,	 47,	 101),	 future	 work	 will	 address	2	 whether	these	are	responsible	for	the	SUMOylation	of	Pol2	in	HU.		3	 	4	 Our	data	point	to	a	specific	role	of	Smc5/6	during	DNA	replication	fork	stalling,	5	 consistent	 with	 the	 localisation	 of	 Smc5/6	 to	 sites	 of	 BrdU	 incorporation	6	 following	 HU	 treatment	 (68,	 102).	 	 Interestingly,	 the	 functional	 importance	 of	7	 Smc5/6	during	DNA	replication	is	still	not	clear:	in	fact,	limiting	the	expression	of	8	 Smc5/6	only	in	late	S	phase	and	G2/M	can	sustain	cell	viability,	suggesting	that	9	 the	complex	main	function	can	be	limited	to	post-replicative	repair,	as	observed,	10	 for	 example,	 for	 Sgs1	 in	 a	 pol32∆	 background	 (66,	 103).	 The	 importance	 of	11	 Smc5/6	 in	 late	 S/G2	 phase,	 however,	 does	 not	 exclude	 a	 role	 of	 the	 complex	12	 during	replication,	underlined	in	this	report	by	Smc5/6	ability	to	co-purify	with	13	 and	SUMOylate	Pol	ε at	replication	forks.			14	 	15	 Extensive	 analysis	 of	 pol2-K571	 or	 po2-sim	 did	 not	 show	 any	 robust	 defect	 in	16	 genome	stability	maintenance	in	response	to	fork	stalling.	One	possible	obstacle	17	 in	elucidating	this	function	might	be	the	redundancy	of	the	pathways	regulating	18	 replication	 forks	 and	 Pol	 ε.	 In	 fact,	 Pol2	 SUMOylation	might	 just	 be	 one	 of	 the	19	 many	 targets	 downstream	 of	 the	 S	 phase	 checkpoint	 response.	 Since	 several	20	 replisome	components	are	phosphorylated	following	checkpoint	activation,	(21,	21	 22,	 26,	 104)),	 the	 loss	 of	 a	 single	 target	 of	 regulation	 might	 not	 produce	 a	22	 phenotype	 and	only	 removal	 of	 such	 redundant	 regulation	might	 elucidate	 the	23	 role	 of	 this	modification.	 Interestingly,	 results	 from	 the	 Zhao	 lab	 indicate	 that	24	
pol2	K571R	is	synthetic	defective	with	the	allele	dpb2-1,	leading	to	an	increase	in	25	
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genomic	 instability	 and	 DNA	 damage	 sensitivity	 (Xiaolan	 Zhao,	 personal	1	 communication).	Since	dpb2-1	shows	a	weaker	association	with	Pol2	C-terminal	2	 (105),	 this	 might	 suggest	 that,	 following	 partial	 destabilisation	 of	 Pol	 ε,	 Pol2	3	 SUMOylation	 becomes	 critical	 in	 promoting/regulating	 DNA	 synthesis.	 In	4	 addition,	 the	 SUMOylation	 might	 regulate	 the	 conformation	 of	 Pol	 ε	 or	 it’s	5	 functional	engagement	to	the	rest	of	the	replisome	and	this	could	become	critical	6	 once	the	 interaction	with	Dpb2	is	weakened.	 Interestingly,	analysis	by	Electron	7	 Microscopy	shows	that	 the	 flexible	 linker	between	the	catalytic	N-terminal	half	8	 of	 Pol2	 and	 the	 Pol2	 C-terminal	 /	 Dpb2	 /	 CMG	 complex	 allows	 either	 for	 a	9	 compressed	conformation	of	Pol2,	or	for	an	extended	one	(106).	It	 is	 intriguing	10	 to	 speculate	 that,	 since	 Pol2	 N-terminal	 is	 SUMOylated	 and	 Pol2	 C-terminal	11	 contains	a	SIM,	this	intramolecular	interaction	might	regulate	the	different	states	12	 of	 conformation	of	Pol2.	This	 could	 represent	a	mechanism	 that	helps	 regulate	13	 Pol	 ε	 activity	 in	 response	 to	 stalling,	 thus	 promoting	 fork	 restart	 once	 the	14	 obstacles	 are	 removed.	 Importantly,	 Rad53	 actively	 regulates	 replisome	15	 progression	 in	 response	 to	 checkpoint	 activation	 (21,	 27-29)	 and	 the	16	 SUMOylation	of	Pol	ε	might	form	part	of	this	regulation.	Alternatively,	in	vivo,	this	17	 interaction	 might	 promote	 Pol	 ε dimerization	 at	 replication	 factories	 (107)	 or	18	 regulate	 the	 catalytic	 activity	 of	 the	 protein.	 Interestingly,	 the	 idea	 of	19	 intramolecular	interaction	between	the	N-terminal	and	the	C-terminal	of	Pol2	or	20	 its	 dimerization	 is	 supported	 by	 the	 observation	 that	 the	 two	 halves	 of	 Pol2	21	 strongly	 interact	even	after	 the	cleavage	of	 the	 flexible	region	connecting	 them	22	 (S8	Fig	A,	B).	While	we	didn’t	observed	large	changes	in	the	level	of	interaction	23	 between	Pol2	N-terminal	and	C-terminal	between	the	SUMOylated	and	the	non-24	 SUMOylated	form	of	the	protein,	more	sensitive	approaches	will	be	required	for	25	
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testing	 the	possibility.	The	use	of	genetic	 code	expansion	and	chemical	biology	1	 approaches	 (108),	might	provide	sufficient	amounts	of	 specifically	SUMOylated	2	 Pol	ε	and	test	this	model.	3	 	4	 Alternatively,	 K571-SUMO	 the	 Pol2-SIM,	 either	 independently	 or	 in	 a	 co-5	 ordinated	manner,	might	be	required	at	the	sites	of	DNA	synthesis	stalling	for	the	6	 effective	 recruitment	 of	 factors	 required	 for	 the	 protection	 or	 repair	 of	7	 replication	forks	(model	shown	in	Fig	6E).	Although	the	presence	or	absence	of	8	 SUMOylation	 did	 not	 qualitatively	 affect	 the	 pattern	 of	 proteins	 co-9	 immunoprecipitating	 with	 Pol	 ε, it	 would	 interesting	 to	 analyse	 whether	 the	10	 levels	of	recruitment	and	the	strength	of	some	of	these	interactions	is	affected	in	11	
pol2	K571R	and	pol2-sim	mutants.				12	 	13	 All	 together,	 here	 we	 have	 described	 a	 novel	 Rad53-dependent	mechanism	 of	14	 regulation	of	the	replisome	mediated	by	the	Smc5/6	complex.	While	the	role	in	15	 genome	 stability	 of	 the	 SUMO-ligase	 activity	 of	Mms21	 in	higher	 eukaryotes	 is	16	 still	 poorly	 understood	 (40,	 62,	 109),	 the	 high	 conservation	 of	 the	 Smc5/6	17	 complex,	Pol	ε	and	the	S	phase	checkpoint	mean	that	it	will	be	of	great	interest	to	18	 explore	whether	Pol2	SUMOylation	also	regulates	replisome	function	in	response	19	 to	replication	stress	in	other	species.			20	 	 	21	
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MATERIAL	AND	METHODS	1	 	2	 Yeast	Strains	and	Growth	Conditions	3	 	4	 The	yeast	strains	used	in	this	study	are	isogenic	to	strain	W303-1	(ade2-1	ura3-1	5	
his3-11,15	trp1-1	leu2-3,112	can1-100),	unless	stated	otherwise.	The	strains	used	6	 are	listed	in	S1	Table.	7	 	8	 All	 yeasts	 were	 grown	 in	 YP	 medium	 (1%	 yeast	 extract,	 2%	 peptone)	9	 supplemented	with	 glucose	 (YPD),	 galactose	 (YPGal),	 or	 raffinose	 (YPRaf)	 to	 a	10	 final	concentration	of	2%	(w/v).	For	solid	media,	the	same	recipe	was	used,	but	11	 with	a	 final	concentration	of	1%	(w/v)	agar.	Alternatively,	minimal	SC	medium	12	 was	 used	 (ammonium	 sulphate	 0.5%	 w/v,	 yeast	 Nitrogen	 base	 0.17%	 w/v,	13	 glucose	 2%,	 SC	 mix	 0.139%	 (Sigma-Aldrich	 Y2021),	 agar	 1%),	 supplemented	14	 with	the	required	amino	acids.	The	default	temperature	used	in	the	experiments	15	 is	24˚C,	unless	specifically	indicated	in	the	experiment.	For	cell	cycle	experiment,	16	 cells	were	grown	to	exponential	phase	(0.7	x	107	cells/ml)	synchronized	in	G1	by	17	 addition	 of	 7.5	 μg/ml	 α-factor	 mating	 pheromone	 (Pepceuticals)	 and	 released	18	 into	 S	 phase	 by	 washing	 twice	 with	 fresh	 YPD	 media.	 To	 induce	 replication	19	 stress,	hydroxyurea	(HU;	Molekula)	was	added	to	a	final	concentration	of	0.2	M,	20	 methyl	 methane	 sulphonate	 (MMS,	 Sigma)	 to	 a	 final	 concentration	 of	 0.033%	21	 v/v,	or	Camptothecin	(CPT,	Sigma)	to	a	final	concentration	of	20	µM.	Cells	were	22	 arrested	in	G2-phase	by	addition	of	5	μg/ml	nocodazole	(Sigma-Aldrich	M1404)	23	 to	 the	 culture	medium	 for	 one	 generation	 time;	 double	 stranded	 breaks	 were	24	 induced	with	Zeocin	(ZEO,	Gibco)	to	a	final	concentration	of	70	µM.	For	analysis	25	 asynchronous	cultures,	cells	were	grown	to	the	concentration	of	1	x	107	cells/ml.		26	 	27	 Yeast-Two-Hybrid	analysis	based	on	the	Gal4	transcription	factor	was	performed	28	 by	co-transformation	of	derivatives	of	pGADT7	(Gal4-activation	domain-HA	tag	29	 (LEU2);	 Clontech)	 or	 pGBKT7	 (Gal4-DNA	 binding	 domain-MYC	 tag	 (TRP1);	30	 Clontech)	 into	 the	 yeast	 strains	 PJ69–4A.	 SC	medium	was	 used,	 either	 lacking	31	 Tryptophan	and	Leucine	 (selective	 for	pGADT7	and	pGBKT7,	but	non-selective	32	 for	 the	 two-hybrid	 interaction)	 or	 lacking	 Tryptophan,	 Leucine,	 Histidine	 or	33	 Tryptophan,	Leucine,	Histidine,	Adenine	(weak	and	strong	selection	for	the	two-34	 hybrid	interaction,	respectively).		35	 	36	 For	 yeast	 two-hybrids	 experiments,	 cells	were	 grown	on	 selective	media,	 until	37	 single	 colonies	were	 visible.	 From	 each	 strain,	 five	 discrete	 colonies	 of	 similar	38	 size	 were	 resuspended	 in	 sterile	 deionised	 water,	 counted,	 and	 diluted	 to	 the	39	 appropriate	concentration.	From	this	suspension,	serial	dilutions	(5	x106,	5	x105,	40	 5	 x104,	 5	 x103	 cells/ml)	 were	 generated.	 Finally,	 10	 µl	 of	 the	 solutions	 were	41	 plated.	42	 Generation	of	mutants	43	 Gene	 deletions	 and	 tagging	 were	 made	 by	 one	 step	 PCR	 transformation	 in	44	 diploids,	 followed	 by	 sporulation	 and	 tetrad	 dissection	 as	 in	 (110,	 111).	 The	45	 allele	pol2-3xTEV-9MYC	was	generated	by	first	inserting	the	URA3	gene	between	46	 3681bp	 -	 3727bp	 of	 POL2	 ORF.	 Cells	were	 then	 transformed	with	 a	 construct	47	 generated	 by	 fusion	 PCR	 and	 composed	 of	 3127-3681	 (POL2	 ORF)-3xTEV	48	
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sequence-	3682-6666	(POL2	ORF)-	9MYC	 tag-	K.l.	TRP1-	+81-518	 (downstream	1	
POL2	 ORF).	 The	 3xTEV	 sequence	 inserted	 is	2	 GASENLYFQGATASENLYFQGSATGAENLYFQGAG.	The	fragment	was	transformed	3	 and	 selected	 first	 with	 K.l.TRP1	 and	 then	 for	 loss	 of	 the	 URA3	 marker.	 For	4	 selection	of	ura3	cells,	5-Fluoroorotic	acid	(5-FOA;	F5001,	Melford	Laboratories)	5	 was	 added	 to	 a	 final	 concentration	 of	 1%	 w/v	 in	 SC	 medium.	 Positive	 clones	6	 were	 analysed	 by	 PCR,	 immunoblotting	 and	 sequencing.	 The	 allele	 pol2K571R	7	 was	 generated	 with	 a	 similar	 strategy,	 first	 by	 deleting	 the	 region	 -95bp	 to	8	 +1726bp	of	POL2	ORF	by	insertion	of	a	URA3	allele,	then	by	generating	by	fusion	9	 PCR	a	construct	-145bp	to	-95bp	(upstream	POL2	ORF)	-K.l.	TRP1-	with	–	370bp	10	 to	+	2049bp	(1712	AGA	1714	to	gaA	ORF	POL2).	Cells	were	first	selected	in	SC-11	 TRP	medium,	 followed	by	SC	5-FOA.	Positive	clones	were	analysed	by	PCR	and	12	 sequencing.	 The	 allele	 pol2sim	 was	 generated	 by	 fusion	 PCR	 using	 a	 strategy	13	 similar	to	C-terminal	tagging,	but	keeping	the	stop	codon	at	the	end	of	the	ORF	so	14	 to	 avoid	 introducing	 any	 tag	 at	 the	 end	 of	 the	 protein.	 This	 introduces	 the	15	 mutation	 between	 position	 6627bp	 –	 6643bp	 (POL2	 ORF)	 from	16	 TTTGATATATTATTG	to	gcTGATgcAgccgct.	Positive	cells	were	tested	by	PCR	and	17	 sequencing.		18	 Plasmids	19	 The	lists	of	the	plasmids	used	in	this	study	are	in	Appendix	Supplementary	Table	20	 S2.	Two-hybrid	plasmids	were	generated	by	recombination	in	budding	yeast,	by	21	 co-transforming	linearized	versions	of	pGADT7	or	pGBKT7		(digested	with	NdeI-22	 XhoI	 and	 NdeI-PstI,	 respectively)	 into	 yeast	 cells,	 together	 with	 PCR	 products	23	 that	 contained	 the	 test	 sequence	 flanked	 by	 50	 bp	 homology	 to	 the	 digested	24	 vector.	 Positive	 clones	 were	 selected	 in	 SC-Leucine	 and	 SC-	 Tryptophan	 (for	25	 pGADT7	 and	 pGBKT7,	 respectively).	 The	 recombined	 plasmids	 were	 then	26	 recovered	 from	yeast,	 amplified	 and	 sequenced.	Point	mutations	of	CysA,	CysB	27	 and	 the	SIM	were	 introduced	by	 fusion	PCR	using	synthetic	DNA	as	a	 template	28	 (Biomatik).	29	 Protein	analysis	30	 Immunoprecipitation	 of	 replication	 proteins	 were	 conducted	 as	 previously	31	 described	(21,	112).	For	immunoblotting	experiments,	about	2.5	×	109	cells	were	32	 used,	while	for	mass	spectrometry	analysis	in	Fig	2A,	2B	(Sld5	IP)	and	5B,	about	33	 1×	 1010	cells	were	 used.	 For	 each	 sample,	 2.5	 g	 of	 cells	was	 ground	 in	 a	 SPEX	34	 SamplePrep	6780	Freezer/Mill.	For	Fig	2B	(Sld5	IP),	the	eluted	material	was	also	35	 precipitated	 with	 ice	 cold	 20%	 TCA	 and	 resuspended	 in	 1x	 Laemmli	 buffer	36	 supplemented	 with	 150mM	 Tris.	 For	 protein	 dephosphorylation,	37	 immunoprecipitated	material	was	washed	three	times	before	being	washed	once	38	 with	 the	 reaction	 buffer	 (as	 provided	 by	 the	 manufacturer)	 and	 then	39	 resuspended	in	a	final	volume	of	50	µl	and	incubated	with	400	units	of	 lambda	40	 phosphatase	 (New	 England	 Biolabs).	 A	 mock-treated	 control	 and	 a	 sample	41	 treated	with	 lambda	phosphatase	and	also	 the	phosphatase	 inhibitors	 -	20	mM	42	 NaVO4,	 and	 50	 mM	 NaF	 -	 were	 also	 included	 in	 the	 experiment	 as	 controls.	43	 Protein	samples	were	incubated	at	30˚C	for	30	min.	Samples	were	then	boiled	in	44	 Laemmli	 buffer	 and	 eluted.	 For	 the	 cleavage	 with	 TEV,	 samples	 were	45	 resuspended	 in	 wash	 buffer	 100	 mM	 potassium	 acetate	 without	 protease	46	 inhibitors	and	incubated	with	20	units	of	AcTEV	(Invitrogen)	and	incubated	for	47	
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2h	at	24˚C.	Analysis	of	the	signal	intensity	was	conducted	using	Fiji.	Unsaturated	1	 exposures	were	used	for	the	analysis.	Cross-linking	immunoprecipitations	were	2	 conducted	as	in	(21).		3	 	4	 Trichloroacetic	acid	(TCA)	protein	extraction	was	conducted	as	described	before	5	 (113).	 The	 TAP	 tag	 was	 detected	 using	 Peroxidase:Anti-Peroxidase	 complex	6	 (Sigma-Aldrich).	 Other	 proteins	 were	 detected	 by	 immunoblotting	 using	7	 polyclonal	antibodies	previously	described	(21,	114,	115),	polyclonal	anti-FLAG	8	 antibody	 (Sigma-Aldrich),	 9E10	 anti-MYC	 antibody	 (Biorad),	 polyclonal	 anti-9	 Rad53	antibody	 (Santa	Cruz)	monoclonal	 anti-Ubiquitin	 (P4D1)	and	polyclonal	10	 antibody	 specific	 for	 a	 histone	H2A	and	histone	H2A	phosphorylated	 at	 Serine	11	 129	 (Abcam).	 The	 anti-SUMO	 antibodies	 used	 were	 the	 described	 in	 (116)	 or	12	 raised	 in	 sheep	 using	 the	 full-length	 Smt3	 protein	 and	 purified	 using	 His6-13	 Smt3GG∆.	14	 	15	 MS	and	analysis	16	 	17	 For	mass	spectrometry	analysis	in	Fig	S2,	each	sample	lane	was	run	into	pre-cast	18	 Novex	Wedgewell	10%	Tris-Glycine	polyacrylamide	gels	and	ran	in	the	supplied	19	 MOPS	 buffer	 for	 10mm	 then	 cut	 into	 10	 bands	 before	 digestion	 with	 trypsin.	20	 Peptides	 were	 analysed	 by	 nanoliquid	 chromatography–tandem	 mass	21	 spectrometry	 with	 an	 Orbitrap	 Fusion	 (Proteomics	 Research	 Technology	22	 Platform,	University	of	Warwick).	For	mapping	of	the	SUMOylation	site,	analysis	23	 of	the	trypsin-digested	peptides	was	conducted	by	MaxQuant.	24	 	25	 SUMOylation	in	vitro.		26	 	27	 His6-Smt3GG∆,	 Ubc9-His6,	 and	 His6-Aos1/Uba2-His6	 (co-expressed	 in	 the	 same	28	 cell)	 were	 expressed	 in	 E.	 coli	 (Rosetta)	 and	 purified	 by	 Ni-NTA	 affinity	29	 purification	 as	 previously	 described	 in	 (117,	 118).	 Smt3GG∆	 and	 Ubc9	30	 preparations	 were	 >99%	 pure	 and	 the	 Uba2/Aos1	 preparation	 >90%.	 All	31	 proteins	 were	 dialyzed	 (Slide-A-Lyzer	 Dialysis	 Cassettes,	 10K	 MWCO,	 Pierce)	32	 with	a	buffer	10%	Glycerol,	50	mM	HEPES	(pH	7.0),	100	mM	NaCl,	10	mM	MgCl2,	33	 0.1	mM	DTT,	 5	mM	Tris,	 20	mM	 imidazole,	 0.5	 μM	ZnCl2.	 Yeast	 proteins	were	34	 purified	from	5g	(TAP-Dpb2)	of	2.5g	(Smc5-TAP)	cell	pellet	as	described	above.	35	 The	 last	 couples	 of	 washes	 of	 the	 magnetic	 beads	 were	 performed	 in	36	 SUMOylation	 buffer	 (without	 ZnCl2).	 The	 in	 vitro	 reactions	 were	 performed	37	 following	AcTEV	elution	of	TAP-Smc5	and	TAP-Dpb2.		Reactions	were	performed	38	 in	siliconised	low	retention	1.5	tubes	and	contained	50	mM	HEPES	(pH	7.0),	100	39	 mM	NaCl,	10	mM	MgCl2,	0.1	mM	DTT,	20	μg/ml	bovine	serum	albumin	(BSA),	5	40	 mM	Tris,	20	mM	pH	8,	imidazole,	0.5	μM	ZnCl2	and	the	following	as	noted:	5	mM	41	 ATP;	 5mM	 SUMO;	 150nM	 Uba2/Aos1	 and	 150	 nM	 Ubc9,	 Pol2	 (20	 µl	 of	 TEV	42	 eluted	material)	and	Smc5	(5-10-15	µl	of	final	elute).	Reactions	were	conducted	43	 at	30˚C	for	1h.	Time	was	started	following	addition	of	ATP	to	the	reaction.		44	 	45	 Measurement	of	DNA	content	46	 	47	
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Cells	were	fixed	and	prepared	for	flow	cytometry	as	described	previously	(119)	1	 and	 then	 analysed	with	 a	 FACScan	 flow	 cytometer	 (Becton-Dickinson)	 and	 BD	2	 CellQuest	(BD	Biosciences).	3	 	 	4	
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Fig	 1.	 Pol2	 is	 mono-SUMOylated	 on	 chromatin	 in	 response	 to	 nucleotide	1	
depletion.	 A)	 Pol2	 is	 post-translationally	 modified	 in	 response	 to	 replication	2	 stress,	 especially	 following	 treatment	 with	 HU.	 Cells	 were	 grown	 to	 the	3	 exponential	phase,	arrested	in	G1	and	synchronously	released	in	S	phase	for	30	4	 min	 in	 YPD	 (S	 phase),	 or	 for	 90	 min	 in	 medium	 containing	 0.2	 M	 HU	 (HU),	5	 0.033%	 methyl	 methanesulphonate	 (MMS)	 or	 20	 µM	 Camptothecin	 (CPT).	6	 Exponentially	 growing	 cells	 were	 also	 arrested	 at	 the	 G2/M	 phase	 with	7	 nocodazole,	 and	 incubated	 in	 the	 absence	 (Nz)	 or	 in	 the	 presence	 of	 70	 µM	8	 Zeocin	 (Nz+NEO)	 for	 90	 min.	 Rad53	 and	 Pol2	 immunoblotting	 are	 shown.	B)	9	 Pol2	 is	 SUMOylated	 in	 response	 to	 HU.	 Cells	 carrying	 a	 TAP-tagged	 version	 of	10	 Dpb2	 were	 grown	 to	 exponential	 phase,	 arrested	 in	 G1	 and	 synchronously	11	 released	in	S	phase	for	30	min	in	YPD	(S	phase)	or	for	90	min	in	YPD	0.2	M	HU	12	 (HU).	Pol	ε	was	purified	under	stringent	conditions	(700	mM	potassium	acetate)	13	 and	the	immunoprecipitated	material	was	eluted	by	TEV	cleavage	of	the	TAP	tag.	14	 Cell	extracts	and	 IPs	were	probed	with	an	anti-SUMO	antibody.	C)	SUMOylated	15	 Pol2	 is	 enriched	 at	 forks.	 Cells	 carrying	 a	 FLAG-tagged	 allele	 of	 Cdc45	 were	16	 grown	to	exponential	phase,	arrested	in	G1	and	synchronously	released	in	YPD	17	 0.2	M	HU	(HU)	for	90	min.	Proteins	were	cross-linked	with	formaldehyde.	Cdc45	18	 was	 immunoprecipitated	 and	 protein	 samples	 were	 analysed	 by	19	 immunoblotting.	D)	Pol2	is	mono-SUMOylated.	(Top).	Schematic	representation	20	 of	the	tagged	alleles	of	POL2	used.	(Bottom).	Cells	carrying	a	TAP-tagged	version	21	 of	 Dpb2	 and	 either	 a	 wild	 type,	 a	 FLAG-tagged	 or	 a	 SUMO-tagged	 versions	 of	22	
POL2	 were	 grown	 to	 exponential	 phase,	 arrested	 in	 G1	 and	 synchronously	23	 released	 in	YPD	0.2	M	HU	for	90	min.	Dpb2	was	 then	purified	and	analysed	by	24	 immunoblotting.	25	
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Fig	 2.	 Pol2	 is	 the	 major	 target	 of	 SUMOylation	 within	 the	 replisome	 in	1	
response	to	nucleotides	depletion.	A)	Pol2	is	the	major	SUMOylation	substrate	2	 among	the	replicative	DNA	polymerases	in	response	to	HU.	Cells	carrying	a	TAP-3	 tagged	version	of	Dpb2	(Pol	ε),	Pol12	(Pol	α)	or	Pol31	(Pol	δ)	were	grown	to	the	4	 exponential	phase,	arrested	in	G1,	and	synchronously	released	in	S	phase	in	the	5	 absence	(S)	or	in	the	presence	of	0.2	M	HU	for	30	min	and	90	min,	respectively.	6	 The	TAP-tagged	proteins	were	 immunoprecipitated	under	stringent	conditions,	7	 eluted	 by	 TEV	 cleavage	 of	 the	 TAP	 tag	 and	 analysed	 by	 immunoblotting.	 The	8	 samples	were	 also	 analysed	 by	mass	 spectrometry	 and	 shown	 to	 co-purify	 all	9	 components	 of	 the	 three	 polymerases	 (S2	 Fig).	 B)	 Pol2	 is	 the	 main	 target	 of	10	 SUMOylation	 within	 the	 replisome	 in	 response	 to	 HU.	 Cells	 carrying	 a	 TAP-11	 tagged	 version	of	Dpb2	 (Pol	 ε)	 or	 Sld5	 (GINS)	were	 synchronously	 released	 in	12	 the	 absence	 (S)	 or	 in	 the	 presence	 of	 0.2	 M	 HU	 for	 30	 min	 and	 90	 min,	13	 respectively.	 The	 TAP-tagged	 proteins	 were	 immunoprecipitated	 from	 2.5*109	14	 (Dpb2-TAP)	 and	 1010	 cells	 (TAP-Sld5)	 in	 300mM	potassium	 acetate,	 eluted	 by	15	 TEV	 cleavage	 of	 the	 TAP	 tag	 and	 (for	 the	 Sld5	 IPs)	 concentrated	 by	 TCA	16	 precipitation.	TAP-Sld5	purification	allows	to	isolate	the	Replisome	Progression	17	 Complex,	 comprising	 of	 the	 CMG	 helicase	 and	 other	 regulatory	 factors	 at	 the	18	 replication	 fork	 (114).	 Protein	 samples	were	 separated	by	 electrophoresis	 and	19	 Coomassie-stained	or	 analysed	by	 immunoblotting.	The	 symbol	<	 indicates	 the	20	 TEV	proteinase	band,	the	symbol	*	indicates	the	un-cleaved	form	of	TAP-Sld5.	21	 	22	
	 	23	
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Fig	 3.	 Pol2	 SUMOylation	 depends	 on	 Rad53	 and	 S	 phase	 checkpoint	1	
mediators.	 A)	 Representation	 of	 the	 checkpoint	 kinases	 cascade.	 	 B)	 Pol2	2	 SUMOylation	depends	on	the	checkpoint	kinases	Mec1	and	Rad53.	Strains	sml1∆	3	 (WT),	sml1∆	mec1∆	 (mec1∆),	sml1∆	rad53∆	 (rad53∆)	and	sml1∆	dun1∆	 (dun1∆),	4	 all	carrying	a	TAP-tagged	version	of	DPB2,	were	grown	to	the	exponential	phase,	5	 arrested	 in	G1	and	synchronously	released	 in	medium	containing	0.2	M	HU	for	6	 90	min.	Dpb2	was	 immunoprecipitated	and	the	protein	samples	were	analysed	7	 by	 immunoblotting.	 C)	 Pol2	 SUMOylation	 depends	 on	 the	 S	 phase	 checkpoint	8	 mediators	Mrc1	and	Ctf18.	Strains	deleted	for	genes	required	for	the	activation	9	 of	Rad53	 in	 response	 to	double	 strand	breaks	 (mre11∆,	rad50∆),	 to	 replication	10	 stress,	 either	 through	 the	 S	 phase	 checkpoint	 (mrc1∆,	 ctf18∆,	mrc1-AQ),	 or	 the	11	 DNA	damage	checkpoint	(rad9∆),	were	grown	to	the	exponential	phase,	arrested	12	 in	G1	and	synchronously	released	in	medium	containing	0.2	M	HU	for	90	min.	Pol	13	
ε	was	 immunoprecipitated	 via	Dpb2-TAP	 and	 analysed	 by	 immunoblotting.	D)	14	 Analysis	of	 the	kinetics	of	Pol2	SUMOylation.	Wild	 type	cells,	mutants	 sld3-37A	15	
dbf4-4A,	and	sml1∆	rad53∆	were	grown	to	the	exponential	phase,	arrested	in	G1	16	 and	 synchronously	 released	 in	medium	 containing	 0.2	M	HU	 for	 90	min.	 Cells	17	 were	collected	every	30	min,	and	proteins	were	analysed	by	TCA	extraction	and	18	 immunoblotting.	Pol2	SUMOylation	appears	after	Rad53	activation	and	it’s	more	19	 pronounced	in	cells	defective	in	the	inhibition	of	late	origin	firing.	20	 	21	
	 	22	
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Fig	 4.	 Pol2	 is	 SUMOylated	 by	 Mms21	 and	 interacts	 with	 the	 Smc5/6	1	
complex.	 A)	 Pol2	 SUMOylation	 depends	 on	 the	 E3-SUMO	 ligase	Mms21.	Wild	2	 type,	siz1∆	and	siz2∆	cells	were	grown	to	the	exponential	phase,	arrested	in	G1	3	 and	 synchronously	 released	 in	 medium	 containing	 0.2	 M	 HU	 for	 90	 min.	 In	4	 addition,	a	control	strain	(Ctr)	and	one	carrying	an	auxin-inducible	degron	allele	5	 of	MMS21	 (mms21),	were	grown	in	YPRaf	 to	 the	exponential	phase,	arrested	 in	6	 G1,	resuspended	in	YPGal	for	35	min,	incubated	for	60	min	in	medium	containing	7	 a	 final	 concentration	 of	 0.5	 mM	 indole-3-acetic	 acid	 (IAA)	 to	 induce	 protein	8	 degradation,	and	released	in	YPGal	containing	0.2	M	HU	and	0.5	mM	IAA	for	90	9	 min.		Dpb2-TAP	was	immunoprecipitated	and	protein	samples	were	analysed	by	10	 immunoblotting.	B)	 Smc5/6	complex	 is	 required	 for	Pol2	SUMOylation.	Strains	11	 wild	type,	mms21-aid	(mms21),	smc5-aid	(smc5),	scc2-aid	scc4-aid	(scc2	scc4)	and	12	 a	 control	 strain	were	grown	 in	YPRaf	 to	 the	exponential	phase,	 arrested	 in	G1,	13	 resuspended	in	YPGal	for	35	min,	incubated	for	60	min	in	medium	containing	a	14	 final	concentration	of	0.5	mM	IAA,	and	released	in	YPGal	medium	containing	0.2	15	 M	 HU	 and	 0.5	 mM	 IAA	 for	 90	 min.	 Dpb2-TAP	 was	 immunoprecipitated	 and	16	 protein	 samples	 were	 analysed	 by	 immunoblotting.	 C)	 Pol2	 is	 SUMOylated	 in	17	
vitro	by	Mms21.	Pol	ε	and	the	Smc5/6	complex	-	either	carrying	a	wild	type	allele	18	 of	MMS21	or	the	SUMO-ligase	defective	mms21-(C200A	H202A)	mutant,	(referred	19	 to	as	mms21-CH,	 also	see	S4	Fig	B)	 -	were	purified	at	high	salt	conditions	(700	20	 mM	potassium	acetate)	via	 a	TAP	 tag	 (on	Dpb2	and	Smc5	 respectively).	 SUMO	21	 (Smt3GG∆),	 the	 E1	 SUMO-activating	 enzymes	 Aos1/Uba2	 and	 the	 E2	 SUMO-22	 conjugating	 enzyme	Ubc9	were	 purified	 from	E.	 coli.	 The	 in	vitro	 SUMOylation	23	 reaction	 was	 conducted	 for	 60	 min	 at	 30°C.	 D)	 Pol2	 SUMOylation	 partially	24	 depends	on	RTT107	and	ESC2.	An	untagged	strain	(Ø),	or	wild	type,	rtt107∆	and	25	
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esc2∆	cells	carrying	a	TAP-tagged	allele	of	DPB2,	were	grown	to	the	exponential	1	 phase,	 arrested	 in	G1	and	 synchronously	 released	 in	medium	containing	0.2	M	2	 HU	 for	 90	min.	 Dpb2-TAP	was	 immunoprecipitated	 and	 protein	 samples	were	3	 analysed	by	 immunoblotting.	E)	 Smc5	 co-immunoprecipitates	with	Pol	 ε	 in	G1	4	 and	 S	 phase.	 Cells	 carrying	 either	 a	 tagged	 or	 untagged	 version	 of	 Dpb2	were	5	 grown	to	exponential	phase,	arrested	in	G1	and	released	in	YPD	for	30	min	(S)	or	6	 in	 YPD	 0.2	 M	 HU	 for	 90	 min	 (HU).	 Dpb2-TAP	 was	 immunoprecipitated	 and	7	 protein	 samples	 were	 analysed	 by	 immunoblotting.	 F)	 Pol2	 co-8	 immunoprecipitates	with	Mms21.	Cells	carrying	a	tagged	or	untagged	version	of	9	 Mms21	 were	 arrested	 in	 G1	 and	 released	 in	 YPD	 0.2	 M	 HU	 for	 90	 min	 (HU).	10	 Mms21-5FLAG	was	immunoprecipitated	and	protein	samples	were	analysed	by	11	 immunoblotting.	G)	Mms21	 interaction	with	Pol	ε	 does	not	depend	on	S	phase	12	 checkpoint	components.	Wild	 type	cells	and	sml1∆	rad53∆,	mrc1∆,	tof1∆,	ctf18∆	13	 and	dcc1∆	mutants,	carrying	a	tagged	version	of	Dpb2,	were	arrested	in	G1	and	14	 synchronously	released	either	in	YPD	for	30	min	(S)	or	in	medium	containing	0.2	15	 M	HU	for	90	min	(HU).	Dpb2-TAP	was	immunoprecipitated	and	protein	samples	16	 were	analysed	by	immunoblotting.		17	 	18	
	 	19	
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Fig	 5.	 Pol2	 is	 SUMOylated	 at	 K571.	 A)	Mms21	 SUMOylates	 Pol2	N-terminal	1	 half.	(Top).	A	graphic	representation	of	the	Pol2	allele	used	in	the	experiment	is	2	 shown.	POL2	was	tagged	at	the	C-terminal	with	a	9MYC	tag.	In	addition,	a	3xTEV	3	 sequence	was	inserted	at	the	position	S1227.	(Bottom).	Wild	type	and	mms21-CH	4	 mutant	cells,	carrying	the	POL2-(3TEV)-9MYC	allele,	were	grown	to	exponential	5	 phase,	arrested	 in	G1	and	synchronously	released	 in	YPD	0.2	M	HU	for	90	min.	6	 Pol2	was	then	immunoprecipitated,	incubated	in	the	presence	or	absence	of	the	7	 20	units	of	TEV	protease,	eluted	by	boiling	and	analysed	by	immunoblotting.	The	8	 N-terminal	part	of	Pol2	was	detected	with	a	polyclonal	antibody	raised	against	9	 the	N-terminal	half	of	Pol2,	while	the	C-terminal	half	was	examined	with	an	anti-10	 MYC	 antibody.	B)	 Mass	 spectrometry	 analysis	 reveals	 a	 single	 putative	 site	 of	11	 SUMOylation	at	Lysine	571.	(Left)	Cells	carrying	a	Dpb2	TAP-tagged	allele	were	12	 synchronously	 released	 in	medium	 containing	 0.2	M	HU	 for	 90	min.	 Pol	 ε	was	13	 immunoprecipitated	at	700	mM	potassium	acetate	and	eluted	by	TEV	cleavage.	14	 Samples	were	 analysed	by	 electrophoresis	 and	 stained	 in	 Coomassie	 blue.	 The	15	 Pol2-SUMO	 band	 was	 cut	 and	 digested	 with	 trypsin	 for	 mass	 spectrometry	16	 analysis.	C)	MS/MS	spectrum	showing	Pol2	modification	at	K571	by	SUMO.	D)	17	 Pol2	SUMOylation	 is	 abolished	 in	a	K571R	mutant.	Cells	 carrying	a	DPB2	TAP-18	 tagged	 allele	 and	 a	 wild	 type	 or	 a	 pol2	 K571R	 (pol2KR)	 allele	 were	 grown	 to	19	 exponential	 phase,	 arrested	 in	 G1	 and	 synchronously	 released	 either	 in	 fresh	20	 medium	 for	 30	min	 (S)	 or	 in	 YPD	 0.2	 M	 HU	 for	 90	min	 (HU).	 Dpb2-TAP	was	21	 immunoprecipitated	 and	 analysed	 by	 immunoblotting.	E)	 K571	 is	 in	 the	 palm	22	 domain	 of	 Pol2.	 Illustration	 of	 the	 position	 of	 K571	 within	 Pol2	 N-terminal	23	 crystal	structure	(81).	K571	is	in	a	Pol2-specific	large	insertion	within	the	palm	24	 domain.		25	
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Fig	 6.	 Pol2	 C-terminal	 contains	 a	 SUMO-interacting	motif	 (SIM).	 A)	The	C-1	 terminal	half	 of	Pol2	 interacts	with	SUMO.	The	ability	of	 the	 subunits	of	Pol	ε-	2	 Dpb2,	 Dpb3,	 Dpb4,	 Pol2	 N-terminal	 (1-1265)	 and	 Pol2	 (1128-2222)	 -	 and	 of	3	 Mrc1	to	interact	with	SUMO	(Smt3AA∆,	an	allele	that	cannot	be	used	as	a	moiety	4	 for	 SUMOylation)	 was	 tested	 by	 using	 the	 yeast	 two-hybrids	 assay.	 Pol2	 C-5	 terminal	shows	the	ability	to	interact	with	SUMO.	B)	Mapping	of	the	interaction	6	 between	several	fragments	of	Pol2	C-terminal	half	and	SUMO	was	tested	by	yeast	7	 two-hybrids	 assay.	 Pol2	 (2013-2222)	 fragment	 is	 sufficient	 for	 the	 interaction	8	 with	SUMO,	while	the	deletion	of	the	last	30	amino	acids	blocks	the	binding.	C)	9	 Identification	of	 a	 SIM	motif	 at	 the	extreme	C-terminal	of	Pol2.	The	analysis	of	10	 the	 sequence	 identified	 a	 putative	 SIM	 sequence	 at	 the	 extreme	 C-terminal.	11	 Mutation	of	this	sequence	abolished	the	binding	of	the	SUMO	protein	while	not	12	 affecting	the	interaction	with	Dpb2.	D)	Pol	ε	composition	and	SUMOylation	is	not	13	 affected	by	the	mutation	of	the	SIM	motif	at	the	C-terminal.	An	untagged	strain,	14	
POL2	 or	pol2sim	 cells	 carrying	a	TAP-tagged	allele	of	DPB2,	were	grown	 to	 the	15	 exponential	phase,	arrested	in	G1	and	synchronously	released	in	YPD	0.2	M	HU	16	 for	 90	 min.	 Dpb2-TAP	 was	 immunoprecipitated	 and	 protein	 samples	 were	17	 analysed	by	 immunoblotting.	E)	Possible	models	of	action	of	Pol2	SUMOylation	18	 in	 response	 to	 replication	 stress.	 Rad53,	 activated	 through	 the	 S	 phase	19	 checkpoint,	and	the	E3	SUMO-ligase	Mms21,	interacting	with	the	Pol	ε,	promote	20	 the	 SUMOylation	 of	 Pol2	 at	 Lysine	 571.	 This	 SUMOylation	 might	 then	 lead	 to	21	 (top)	an	intramolecular	binding	of	SUMO	by	Pol2	SIM	(or	dimerization),	(middle)	22	 recruitment	of	a	SUMOylated	factor	at	forks,	or	(bottom)	recruitment	of	different	23	 proteins	by	the	SUMO	and	SIM	sequences.		24	 	25	
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S1	Fig.	Pol2	SUMOylation	is	mainly	stimulated	by	HU.	A)	Pol2	modification	is	1	 not	sensitive	to	phosphatase	treatment.	 	Cells	carrying	a	TAP-tagged	version	of	2	 DPB2	 were	 grown	 to	 exponential	 phase,	 arrested	 in	 G1	 and	 synchronously	3	 released	in	S	phase	for	30	min	in	YPD	(S	phase)	or	for	90	min	in	YPD	0.2	M	HU	4	 (HU).	Pol	ε	was	purified	under	stringent	conditions	(700	mM	potassium	acetate)	5	 and	incubated	with	lambda	phosphatase,	both	in	the	presence	or	absence	of	the	6	 phosphatase	 inhibitors	 20	 mM	 sodium	 vanadate	 (NaVO4)	 and	 50	 mM	 sodium	7	 fluoride	 (NaF).	 A	 mock-treated	 sample	 was	 used	 as	 a	 control.	 While	 the	8	 phosphatase	 is	 able	 to	 dephosphorylate	 components	 of	 the	 replisome	 (such	 as	9	 Mcm4),	the	upper	band	appearing	over	Pol2	in	HU	is	not	affected.	B)	Pol2	is	not	10	 ubiquitylated.	Samples	 from	Fig	1B	were	probed	by	 immunoblotting	with	anti-11	 Ubiquitin	 antibody.	 No	 specific	 band	 is	 recognised	 in	 the	 Dbp2-TAP	12	 immunoprecipitated	 material	 following	 HU	 exposure.	 C)	 Pol2	 is	 SUMOylated	13	 preferentially	in	response	to	HU	treatment.	Cells	carrying	a	TAP-tagged	version	14	 of	Dpb2,	as	well	a	tagged	version	of	Sld3	and	Mrc1,	were	treated	as	described	in	15	 Fig	 1A.	 Dpb2	 was	 then	 purified	 and	 analysed	 by	 immunoblotting.	 Pol2	16	 SUMOylation	occurs	to	a	low	level	during	a	normal	phase	and	it	is	preferentially	17	 stimulated	 following	 HU	 treatment.	 D)	 Analysis	 of	 checkpoint	 activation	18	 following	different	genotoxic	treatments.	Cells	from	the	experiment	above	were	19	 collected;	 protein	 samples	 were	 obtained	 by	 TCA	 extraction	 and	 analysed	 by	20	 immunoblotting.	 	Strikingly,	MMS	stimulates	 the	phosphorylation	of	Mrc1,	Sld3	21	 and	Rad53	to	a	similar	extent	than	HU.	22	
	 	23	
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	S2	Fig.	Mass	spectrometry	analysis	of	the	replicative	DNA	polymerases.	The	1	 samples	shown	in	Fig	2A	were	analysed	by	mass	spectrometry.	We	observe	that	2	 all	the	subunits	of	the	DNA	polymerases	are	present.		3	
	 	4	
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S3	 Fig.	Defects	 in	 Rad53	 activation	 greatly	 decrease	 Pol2	 SUMOylation	 in	1	
HU.	 A)	 Wild	 type,	 ctf18∆	 and	 ctf18-2A	 (76)	 cells	 were	 arrested	 in	 G1	 and	2	 synchronously	released	in	YPD	0.2	M	HU.	Cells	samples	were	taken	every	15	min	3	 and	analysed	by	immunoblotting.	B)	The	S	phase	checkpoint	is	required	for	the	4	 10-fold	 increase	 in	Pol2	SUMOylation	 in	 response	 to	HU.	Wild	 type,	mrc1∆	 and	5	
rad53∆,	 all	 deleted	 for	 SML1	 and	 carrying	 a	 TAP-tagged	 allele	 of	 DPB2,	 were	6	 arrested	 in	 G1	 before	 being	 released	 in	 the	 medium	 containing	 0.2	 M	 HU	 or	7	 0.03%	MMS	for	90	min.	Celle	extracts	were	used	for	immunoprecipitation	of	TAP	8	 and	analysed	by	immunoblotting.		9	
	 	10	
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	S4	 Fig.	 Analysis	 of	 the	 sensitivity	 to	 auxin-	 of	 the	 mutants	mms21-aid,	1	
smc5-aid	 and	 scc2-aid	 scc4-aid.	 A)	 Serial	 dilutions	 were	 spotted	 on	 YPGal	2	 plates,	with	or	without	0.5	mM	IAA,	and	 incubated	at	30˚C	 for	2	days.	B)	FACS	3	 analysis	 of	 the	 cell	 cycle	 progression	 following	 depletion	 of	 Smc5,	Mms21	 and	4	 Scc2	Scc4.	Cells	were	grown	 in	YPRaf	 to	 the	exponential	phase,	 arrested	 in	G1,	5	 resuspended	in	YPGal	for	35	min,	incubated	for	60	min	in	medium	containing	a	6	 final	concentration	of	0.5	mM	IAA	to	induce	protein	degradation,	and	released	in	7	 YPGal	0.2	M	HU	and	0.5	mM	IAA	for	90	min.	At	this	point,	the	samples	used	for	8	 the	 experiment	 show	 in	 Fig	 4B	were	 taken.	 Cells	were	 then	washed	 twice	 and	9	 released	in	YPGal	0.5	mM	IAA.	α-factor	was	added	to	block	re-entry	in	the	next	10	 cell	cycle.	11	
	 	12	
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S5	Fig.	Pol2	SUMOylation	depends	on	Mms21.	A)	Mms21	is	required	for	the	1	 basal	 levels	of	SUMOylation	during	S	phase.	Cells	were	treated	as	in	Fig	4A,	but	2	 released	 in	 S	 phase	 in	 YPD	 medium	 for	 30	 min.	 Dpb2-TAP	 was	3	 immunoprecipitated	and	protein	samples	were	analysed	by	immunoblotting.	B)	4	 Rad53	does	not	regulate	 the	basal	 levels	of	SUMOylation	 in	S	phase.	Wild	 type,	5	
rad53∆	and	rmm3∆	cells,	all	deleted	for	SML1	and	carrying	a	TAP-tagged	allele	of	6	
DPB2,	 were	 synchronously	 released	 in	 S	 phase	 in	 YPD	medium	 for	 30	min	 at	7	 24˚C.	Dpb2-TAP	was	immunoprecipitated	and	protein	samples	were	analysed	by	8	 immunoblotting.	C)	Point	mutation	of	the	sp-RING	domain	of	MMS21	blocks	Pol2	9	 SUMOylation.	 Cells	 carrying	 a	 TAP-tagged	 version	 of	 Dpb2	 and	 a	 Mms21	 or	10	
mms21-(C200A	H202A)	(mms21-CH)	allele	were	grown	to	the	exponential	phase,	11	 arrested	 in	 G1,	 and	 released	 in	 YPD	 0.2	 M	 HU.	 Dpb2-TAP	 was	12	 immunoprecipitated	 and	 analysed	 by	 immunoblotting.	 D)	 Re-expression	 of	13	 Mms21	leads	to	Pol2	SUMOylation.	Cells	Dpb2-TAP	mms21-CH,	with	or	without	a	14	 second	allele	of	MMS21	under	the	GAL1,10	promoter,	were	grown	in	YPRaf	to	the	15	 exponential	 phase,	 arrested	 in	 G1,	 and	 synchronously	 in	 YPRaf	 medium	16	 containing	 0.2	 M	 HU	 for	 75	 min.	 Cells	 were	 resuspended	 and	 incubated	 for	17	 further	 60	 min	 either	 in	 YPRaf	 0.2	 M	 HU	 or	 YPGal	 0.2	 M	 HU.	 Dpb2-TAP	 was	18	 immunoprecipitated	 and	 analysed	 by	 immunoblotting.	 Mms21	 re-expression	19	 leads	to	the	SUMOylation	of	Pol2	(its	co-immunoprecipitation	with	Dpb2).	20	
	 	21	
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S6	 Fig.	 Pol	 ε 	 and	 the	 Smc5/6	 complex	 interact	 both	 in	 G1	 and	 S	 phase,	1	
independently	of	 the	 S	phase	 checkpoint.	A)	Mms21	co-immunoprecipitates	2	 with	Dpb2.	Cells	were	treated	as	in	Fig	4E,	but	instead	of	a	FLAG-tagged	version	3	 of	 Smc5,	 they	 carried	 a	 FLAG-tagged	 version	 of	 Mms21.	 B)	 Pol	 ε	 co-4	 immunoprecipitates	with	Smc5.	Cells	carrying	either	a	TAP-tagged	or	untagged	5	 version	of	Smc5	were	grown	to	exponential	phase,	arrested	in	G1,	and	released	6	 either	in	YPD	for	30	min	(S)	or	in	YPD	0.2	M	HU	for	90	min	(HU).	Smc5-TAP	was	7	 immunoprecipitated	and	protein	samples	were	analysed	by	immunoblotting.	C)	8	 Analysis	of	the	salt-sensitivity	of	the	interaction	between	Dpb2	and	Mms21.	Cells	9	 carrying	 a	 TAP-tagged	 version	 of	 Dpb2	 and	 a	 FLAG-tagged	 version	 of	 Mms21	10	 were	grown	to	exponential	phase,	arrested	in	G1,	and	released	in	YPD	for	30	min.	11	 Dpb2-TAP	was	immunoprecipitated	and	washed	in	solutions	containing	different	12	 concentration	 of	 potassium	 acetate	 (KOAc),	 as	 indicated	 in	 the	 figure.	 The	 IPs	13	 were	eluted	by	boiling	in	Laemmli	buffer	and	protein	samples	were	analysed	by	14	 immunoblotting.	 D)	 Mec1	 and	 the	 SUMO-ligase	 activity	 of	 Mms21	 are	 not	15	 required	 for	 the	 co-purification	 between	 Smc5	 and	 Dpb2.	 Cells	 sml1∆,	 sml1∆	16	
mec1∆,	sml1∆	rad53∆,	mrc1∆	and	mms21-CH	carrying	either	a	tagged	version	of	17	
DPB2	were	 grown	 to	 exponential	 phase,	 arrested	 in	G1,	 and	 released	 either	 in	18	 YPD	 for	 30	 min	 (S)	 or	 in	 YPD	 0.2	 M	 HU	 for	 90	 min	 (HU).	 Dpb2-TAP	 was	19	 immunoprecipitated	and	protein	samples	were	analysed	by	immunoblotting	20	
	 	21	
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S7	Fig.	Pol2	C-terminal	 interacts	with	SUMO.	A)	Controls	for	the	interactions	1	 shown	 in	 Fig	 6A.	 The	 indicated	 fragments	 were	 transformed	 either	 with	 an	2	 empty	plasmid	(negative	control)	and	an	interacting	fragment	(positive	control).	3	
B)	Controls	for	the	interactions	shown	in	Fig	6B.	The	indicated	fragments	were	4	 transformed	 either	 with	 an	 empty	 plasmid	 (negative	 control,	 top)	 or	 with	 a	5	 plasmid	expressing	Dpb2	(positive	control,	bottom).	C)	The	conserved	CysA	and	6	 CysB	 sequences	 at	 Pol2	 C-terminal	 do	 not	mediate	 the	 interaction	with	 SUMO.	7	 Wild	type	Pol2	fragment	2103-2222,	an	allele	mutated	for	CysA	(C2108S	C2111S,	8	
CysA_mut),	 and	 an	 allele	 mutated	 for	 CysB	 (C2164S	 C2167S,	 CysB_mut)	 were	9	 tested	 for	 the	 ability	 to	 interact	 with	 SUMO	 (Smt3AA∆).	 Negative	 (empty	10	 plasmid)	 and	 positive	 controls	 (Dpb2)	 were	 also	 included.	 As	 previously	11	 reported	(103),	CysB	plays	a	major	role	in	mediating	the	interaction	with	Dpb2.	12	 	 	13	
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S8	 Fig.	 Pol2	 N-terminal	 and	 C-terminal	 halves	 interact.	 A)	 Wild	 type	 and	1	
mms21-CH	 cells,	 carrying	 the	 POL2-(3TEV)-9MYC	 allele	 at	 the	 genomic	 locus,	2	 were	grown	to	exponential	phase,	arrested	in	G1	and	synchronously	released	in	3	 YPD	 0.2	 M	 HU	 for	 90	 min.	 Pol2	 was	 then	 immunoprecipitated	 with	 anti-MYC	4	 beads	under	high	salt	conditions	(500	mM	potassium	acetate)	before	incubation	5	 with	TEV	protease	at	24˚C	for	2	h.	Next,	sample	were	eluted	by	boiling	(no	wash),	6	 or	washed	five	times	with	buffers	with	different	salt	concentration	(100	mM,	300	7	 mM	 or	 1M	 potassium	 acetate),	 before	 elution	 by	 boiling.	 All	 samples	 were	8	 analysed	 by	 immunoblotting.	 The	N-terminal	 part	 of	 Pol2	was	 detected	with	 a	9	 polyclonal	 antibody	 raised	 against	 the	 N-terminal	 half	 of	 Pol2,	 while	 the	 C-10	 terminal	half	was	examined	with	an	anti-MYC	antibody.	The	asterisk	indicates	a	11	 background	band.		B)	Analysis	of	the	signal	in	A).	The	plots	show	the	ratio	of	the	12	 signal	of	the	N-terminal	and	SUMO	immunoblots	divided	by	the	signal	of	the	C-13	 terminal	 blot.	 Both	 the	 cut	 and	 full-length	 (FL)	 fractions	 were	 analysed.	 The	14	 ratios	were	then	normalized	against	the	values	of	“no	wash”.	15	 	 	16	
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S1	Table.	List	of	yeast	strains.	1	
S2	Table.	List	of	plasmids.	2	 	3	
Table S1 Yeast strains list W303-1	 R. Rothstein MATa	ade2-1	ura3-1	his3-11,15	trp1-1	leu2-3,112	can1-100	/		MATα	ade2-1	ura3-1	his3-11,15	trp1-1	leu2-3,112	can1-100	W303-1a	 R. Rothstein MATa	ade2-1	ura3-1	his3-11,15	trp1-1	leu2-3,112	can1-100	YAC53	 K.	Labib	 MATa	sml1∆::HIS3	rad53∆::ADE2	CS29	 K.	Labib	 MATa	ctf18∆::K.l.TRP1	CS43	 K.	Labib	 MATa	NTAP2-SLD5	(kanMX)	MCM4-5FLAG	(hphNT)	pep4∆::URA3	ADE2+	CS330	 This	study	 MATa	DPD2-TAP	(kanMX)	pep4∆::ADE2	CS346	 This	study	 MATa	DPB2-TAP	(kanMX)	siz1∆::URA3CP	pep4∆::ADE2		CS347	 This	study	 MATa	DPB2-TAP	(kanMX)	siz2∆::hphNT	pep4∆::ADE2	CS348	 This	study	 MATa	 DPB2-TAP	 (kanMX)	 MMS21-3xaid	 (hphNT)	 ura3-1::GAL1-OsTIR1-9MYC	(K.l.	TRP1)	pep4∆::ADE2	CS358	 This	study	 MATa	DPB2-TAP	(kanMX)	POL2-5FLAG-9HIS	(hphNT)	pep4∆::ADE2	CS359	 This	study	 MATa	DPB2-TAP	(kanMX)	ura3-1::GAL1-OsTIR1-9MYC	(K.l.	TRP1)	SMC5-3xaid	(HIS3MX)	pep4∆::ADE2	CS361	 This	study	 MATa	DPB2-TAP	(kanMX)	ura3-1::GAL1-OsTIR1-9MYC	(K.l.	lTRP1)	SCC2-3xaid	(kanMX)	SCC4-3xaid	(hphNT)	pep4∆::ADE2	CS367	 This	study	 MATa	 DPB2-TAP	 (kanMX)	 MMS21-5FLAG	 (hphNT)	 sml1∆::HIS3	pep4∆::ADE2	CS369	 This	study	 MATa	DPB2-TAP	(kanMX)	SMC5-5FLAG	(hphNT)	sml1∆::HIS3	pep4∆::URA3	rad53∆::ADE2	CS370	 This	study	 MATa	 DPB2-TAP	 (kanMX),	 MMS21-5FLAG	 (hphNT)	 sml1∆::HIS3,	pep4∆::URA3	rad53∆::ADE2	CS379	 This	study	 MATa	DPB2-TAP	 (kanMX)	 pep4∆::ADE2	mms21(C200A	H202A)	 (K.l.	TRP1)	CS383	 This	study	 MATa	SMC5-TAP	(kanMX),	MRC1-18MYC	(K.l.	TRP1)	pep4∆::URA3	CS385	 This	study	 MATa	DPB2-TAP	(kanMX)	MRC1-5FLAG	(hphNT)	SLD3-9MYC	(LEU2)	
pep4∆::ADE2	CS386	 This	study	 MATa	 DPB2-TAP	 (kanMX)	 MMS21-5FLAG	 (hphNT)	 sml1∆::HIS3,	pep4∆::ADE2	ctf18∆::K.l.	TRP1	CS387	 This	study	 MATa	 DPB2-TAP	 (kanMX)	 MMS21-5FLAG	 (hphNT)	 sml1∆::HIS3	pep4∆::ADE2	dcc1∆::hphNT	CS388	 This	study	 MATa	 DPB2-TAP	 (kanMX)	 MMS21-5FLAG	 (hphNT)	 sml1∆::HIS3	pep4∆::ADE2	mrc1∆::hphNT	CS389	 This	study	 MATa	 DPB2-TAP	 (kanMX),	 MMS21-5FLAG	 (hphNT),	 sml1∆::HIS3	pep4∆::ADE2,	tof1∆::HIS3MX	CS427	 This	study	 MATa	 SMC5-TAP	 (kanMX)	 MRC1-18MYC	 (klTRP1)	 pep4∆::URA3	
(C200A	H202A)		(klTRP1)	CS445	 This	study	 MATa	 DPB2-TAP	 (kanMX)	 mms21(C200A	 H202A)	 (klTRP1)	pep4∆::ADE2	ura3-1::GAL-MMS21-5FLAG	(URA3)	CS447	 This	study	 MATa	DPB2-TAP	(kanMX)	SMC5-5FLAG	(hphNT)	ctf18∆::klTRP1	pep4∆::ADE2	CS448	 This	study	 MATa	DPB2-TAP	(kanMX)	SMC5-5FLAG	(hphNT)	mrc1∆::klTRP1	pep4∆::ADE2	CS449	 This	study	 MATa	 DPB2-TAP	 (kanMX)	 SMC5-5FLAG	 (hphNT)	 mms21(C200A	H202A)		(klTRP1)	pep4∆::ADE2	CS459	 This	study	 MATa	DPB2-TAP	(kanMX)	SMC5-5FLAG	(hphMX)	pep4∆::ADE2	sml1∆::HIS3	mec1∆::ADE2	CS460	 This	study	 MATa	DPB2-TAP	(kanMX)	MMS21-5FLAG	(hphMX)	pep4∆::ADE2	sml1∆::HIS3	mec1∆::ADE2	CS476	 This	study	 MATa	 DPB2-TAP	 (kanMX),	 POL2-SMT3_∆GGATY	 (hphNT),	pep4∆::ADE2	CS513	 This	study	 MATa	pol2_(3TEV	sites	N1227)-9MYC	(klTRP1)	pep4∆::ADE2	CS531	 This	study	 MATa	 	 pol2_(3TEV	 sites	 N1227)-9MYC	 (klTRP1),	 mms21	 (C200A	H202A)	(K.l.	TRP1),	pep4∆::ADE2	CS558	 This	study	 MATa	DPB2-TAP	(kanMX)	POL2	(klTRP1)	pep4∆::ADE2	CS561	 This	study	 MATa	DPB2-TAP	(kanMX)	POL2_K571R	(klTRP1)	pep4∆::ADE2	CS767	 This	study	 MATA	REV1-5	FLAG	(kanMX)	
CS936	 This	study	 MAT	 A	 DPB2-TAP	 (kanMX)	 ura3-1::GAL1-OsTIR1-9MYC	 (klTRP1)	pep4∆::ADE2	CS937	 This	study	 MATa	DPB2-TAP	(kanMX)	pep4∆::ADE2	esc2∆::HIS3MX	CS938	 This	study	 MAT	A	REV1-5FLAG	(kanMX)	mms21	(C200A	H202A)	(klTRP1)	CS1006	 This	study	 MATa	POL12-TAP	(kanMX)	pep4Δ::ADE2	CS1007	 This	study	 MATa	POL31-TAP	(kanMX)	pep4Δ::ADE2	CS1177	 K.	Labib	 MATa	ctf18	(W736A,	W740A)	(K.l.	TRP1)	CS3978	 This	study	 MATa	DPB2-TAP	(kanMX)	pep4∆::ADE2	rtt107∆::hphNT	CS3982	 This	study	 MATa	DPB2-TAP	(kanMX)	pep4∆::ADE2	pol2sim	(K.l.	TRP1,	kanMX)	GDP4	 K.	Labib	 MATa	sml1∆::HIS3	mec1∆::ADE2	GDP1341	 This	study	 MATa	DPB2-TAP	(kanMX)	pep4∆::ADE2	sml1∆::HIS3MX		GDP1343	 This	study	 MATa	DPB2-TAP	(kanMX)	pep4∆::ADE2	sml1∆::HIS3	mec1∆::ADE2	GDP1345	 This	study	 MATa	DPB2-TAP	(kanMX)	pep4∆::ADE2	sml1∆::HIS3	rad53∆::ADE2	GDP1347	 This	study	 MATa	DPB2-TAP	(kanMX)	pep4∆::ADE2	sml1∆::HIS3	dun1∆::LEU2	GDP1349	 This	study	 MATa	DPB2-TAP	(kanMX)	pep4∆::ADE2	mre11∆::kanMX	GDP1351	 This	study	 MATa	DPB2-TAP	(kanMX)	pep4∆::ADE2	rad50∆::kanMX		GDP1353	 This	study	 MATa	DPB2-TAP	(kanMX)	ctf18∆::	K.l.	TRP1	pep4∆::ADE2	GDP1355	 This	study	 MATa	DPB2-TAP	(kanMX)	mrc1∆::	K.l.	TRP1	pep4∆::ADE2	GDP1357	 This	study	 MATa	DPB2-TAP	(kanMX)	rad9∆::HIS3MX	pep4∆::ADE2	GDP1359	 This	study	 MATa	DPB2-TAP	(kanMX)	mrc1AQ-13MYC	(his5+)	pep4∆::ADE2	GDP1380	 This	study	 MATa	 DPB2-TAP	 (kanMX)	 SMC5-5FLAG	 (hphNT)	 sml1∆::HIS3	pep4∆::ADE2	GDP1382	 This	study	 MATa	SMC5-5FLAG	(hphNT)	sml1∆::HIS3	pep4∆::ADE2	GDP1386	 This	study	 MATa	MMS21-5FLAG	(hphNT)	sml1∆::HIS3	pep4∆::ADE2	GDP1675	 This	study	 MATa	DPB2-TAP	(kanMX)	rrm3∆	(kanMX)	sml1∆::HIS3	pep4∆::ADE2	PJ69–4A	 H.	Ulrich	 MATa	 trp1-901	 leu2-3,112	 ura3-52	 his3-200	 gal4∆	 gal80∆	LYS2::GAL1-HIS3	GAL2-ADE2	met2::GAL7-lacZ	SS3	 K.	Labib	 MATa		pep4∆::ADE2		yPZ604	 J	Diffley	 MATa	dbf4-4A	(HIS3)	sld3-	37A-10HIS-13MYC	(KanMX)		
Table	S2	Plasmid	list			pCS206	 This	study	 pGBKT7-	SMT3AA∆	pCS207	 This	study	 pGADT7-5GA-Pol2	(2013-2222)	pCS208	 This	study	 GADT7-	Pol2	(2013-2192)	pCS209	 This	study	 pGADT7-Pol2	(2013-2222sim)	F2210A	I2212A	L2213A	L2214A	pCS210	 This	study	 pGADT7-	Pol2	(2013-2222-CysA_mut)	C2108S	C2111S	pCS211	 This	study	 pGADT7-	Pol2	(2013-2222-CysB_mut)	C2164S	C2167S	pHM27	 This	study	 pGADT7-5GA-Mrc1	pKL273	 This	study	 pRS425	pKL559	 Clonetech	 pGADT7	(GAL4	AD)	pKL560	 Clonetech	 pGBKT7	(GAL4	BD)	pKL1436	 Johnson,	E.S		 pET-UBC9-6HIS	pKL1437	 Johnson,	E.S		 pET-SMT3-6HIS	pKL1438	 Johnson,	E.S		 pET-Uba2/Aos1-6HIS	pKL1439	 Johnson,	E.S		 pET-Uba2/Aos1-6HIS	pKL1563	 This	study	 5GA-SUMO(1-99)	C-terminal	tagging	pLG15	 K.	Labib	 pGADT7,	POL2	(1-1265)	pLG17	 K.	Labib	 pGADT7,	POL2	(1128-2222)	pLG18	 K.	Labib	 pGBKT7-POL2	(1128-2222)	pLG23	 This	study	 pGADT7-DPB2	pLG24	 This	study	 pGBKT7-DPB2	pLG47	 This	study	 pGADT7-5GA-Pol2	(1128-1483)	pLG48	 This	study	 pGADT7-5GA-Pol2	(1128-1777)	pLG49	 This	study	 pGADT7-5GA-Pol2	(1128-2107)	pLG69	 This	study	 pGADT7-5GA-Pol2	(1986-2222)	pLG99	 K.	Labib	 pGADT7-DPB3,	5GA	linker	pLG100	 K.	Labib	 pGADT7-DPB4,	5GA	linker	pLG119	 K.	Labib	 pGBKT7,	DPB3,	5GA	linker	pLG120	 K.	Labib	 pGBKT7,	DPB4,	5GA	linker		
